<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mov Disord</journal-id>
<journal-id journal-id-type="iso-abbrev">Mov. Disord</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)1531-8257</journal-id>
<journal-id journal-id-type="publisher-id">MDS</journal-id>
<journal-title-group>
<journal-title>Movement Disorders</journal-title>
</journal-title-group>
<issn pub-type="ppub">0885-3185</issn>
<issn pub-type="epub">1531-8257</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30485556</article-id>
<article-id pub-id-type="pmc">6587951</article-id>
<article-id pub-id-type="doi">10.1002/mds.27484</article-id>
<article-id pub-id-type="publisher-id">MDS27484</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Eye movement disorders and neurological symptoms in late‐onset inborn errors of metabolism</article-title>
<alt-title alt-title-type="right-running-head">Eye Movement Disorders in Late‐Onset Iem</alt-title>
<alt-title alt-title-type="left-running-head">Koens et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="mds27484-cr-0001">
<name>
<surname>Koens</surname>
<given-names>Lisette H.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="mds27484-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mds27484-cr-0002">
<name>
<surname>Tijssen</surname>
<given-names>Marina A.J.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="mds27484-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mds27484-cr-0003">
<name>
<surname>Lange</surname>
<given-names>Fiete</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="mds27484-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mds27484-cr-0004">
<name>
<surname>Wolffenbuttel</surname>
<given-names>Bruce H.R.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="mds27484-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mds27484-cr-0005">
<name>
<surname>Rufa</surname>
<given-names>Alessandra</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="mds27484-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mds27484-cr-0006">
<name>
<surname>Zee</surname>
<given-names>David S.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="mds27484-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="mds27484-cr-0007">
<name>
<surname>de Koning</surname>
<given-names>Tom J.</given-names>
</name>
<degrees>MD, PhD</degrees>
<address>
<email>t.j.de.koning@umcg.nl</email>
</address>
<xref ref-type="aff" rid="mds27484-aff-0006">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="mds27484-aff-0007">
<sup>7</sup>
</xref>
</contrib>
</contrib-group>
<aff id="mds27484-aff-0001">
<label><sup>1</sup></label>
<institution>University of Groningen, University Medical Center Groningen, Department of Neurology</institution>
<named-content content-type="city">Groningen</named-content>
<country country="NL">The Netherlands</country>
</aff>
<aff id="mds27484-aff-0002">
<label><sup>2</sup></label>
<institution>University of Groningen, University Medical Center Groningen, Department of Clinical Neurophysiology</institution>
<named-content content-type="city">Groningen</named-content>
<country country="NL">The Netherlands</country>
</aff>
<aff id="mds27484-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Endocrinology</named-content>
<institution>University of Groningen, University Medical Center Groningen</institution>
<named-content content-type="city">Groningen</named-content>
<country country="NL">The Netherlands</country>
</aff>
<aff id="mds27484-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Medicine Surgery and Neurosciences</named-content>
<institution>University of Siena, Eye tracking and Visual Application Lab (EVA Lab)–Neurology and Neurometabolic Unit</institution>
<named-content content-type="city">Siena</named-content>
<country country="IT">Italy</country>
</aff>
<aff id="mds27484-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Neuroscience, Department of Ophthalmology</named-content>
<institution>The Johns Hopkins University, The Johns Hopkins Hospital, Department of Neurology, Department of Otolaryngology‐Head and Neck Surgery</institution>
<named-content content-type="city">Baltimore</named-content>
<named-content content-type="country-part">Maryland</named-content>
<country country="US">USA</country>
</aff>
<aff id="mds27484-aff-0006">
<label><sup>6</sup></label>
<institution>University of Groningen, Division of Metabolic Diseases, University Medical Center Groningen</institution>
<named-content content-type="city">Groningen</named-content>
<country country="NL">The Netherlands</country>
</aff>
<aff id="mds27484-aff-0007">
<label><sup>7</sup></label>
<institution>University of Groningen, Department of Genetics, University Medical Center Groningen</institution>
<named-content content-type="city">Groningen</named-content>
<country country="NL">The Netherlands</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold> to: Dr. Tom J. de Koning, Department of Genetics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, P.O. Box 30.001, 9700 RB Groningen, The Netherlands; E‐mail: <email>t.j.de.koning@umcg.nl</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2018</year>
</pub-date>
<volume>33</volume>
<issue>12</issue>
<issue-id pub-id-type="doi">10.1002/mds.v33.12</issue-id>
<fpage>1844</fpage>
<lpage>1856</lpage>
<history>
<date date-type="received">
<day>23</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>03</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 International Parkinson and Movement Disorder Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Movement Disorders</italic> published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:MDS-33-1844.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Inborn errors of metabolism in adults are still largely unexplored. Despite the fact that adult‐onset phenotypes have been known for many years, little attention is given to these disorders in neurological practice. The adult‐onset presentation differs from childhood‐onset phenotypes, often leading to considerable diagnostic delay. The identification of these patients at the earliest stage of disease is important, given that early treatment may prevent or lessen further brain damage. Neurological and psychiatric symptoms occur more frequently in adult forms. Abnormalities of eye movements are also common and can be the presenting sign. Eye movement disorders can be classified as central or peripheral. Central forms are frequently observed in lysosomal storage disorders, whereas peripheral forms are a key feature of mitochondrial disease. Furthermore, oculogyric crisis is an important feature in disorders affecting dopamine syntheses or transport. Ocular motor disorders are often not reported by the patient, and abnormalities can be easily overlooked in a general examination. In adults with unexplained psychiatric and neurological symptoms, a special focus on examination of eye movements can serve as a relatively simple clinical tool to detect a metabolic disorder. Eye movements can be easily quantified and analyzed with video‐oculography, making them a valuable biomarker for following the natural course of disease or the response to therapies. Here, we review, for the first time, eye movement disorders that can occur in inborn errors of metabolism, with a focus on late‐onset forms. We provide a step‐by‐step overview that will help clinicians to examine and interpret eye movement disorders. © 2018 The Authors. <italic>Movement Disorders</italic> published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="mds27484-kwd-0001">eye movement disorders</kwd>
<kwd id="mds27484-kwd-0002">inborn errors of metabolism</kwd>
<kwd id="mds27484-kwd-0003">movement disorders</kwd>
<kwd id="mds27484-kwd-0004">adult‐onset</kwd>
</kwd-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="4"></table-count>
<page-count count="13"></page-count>
<word-count count="9763"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>mds27484</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>December 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.4 mode:remove_FC converted:21.06.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group>
<fn id="mds27484-note-0001">
<p>
<bold>Relevant conflicts of interest/financial disclosures</bold>: Nothing to report.</p>
</fn>
<fn id="mds27484-note-0002">
<p>Full financial disclosures and author roles may be found in the online version of this article.</p>
</fn>
</fn-group>
</notes>
</front>
<body>
<p>Inborn errors of metabolism (IEM) are a heterogeneous group of genetic disorders that cause dysfunction of an enzyme or transporter involved in cellular metabolism. Historically, inborn errors were thought to be rare, occuring in less than 1 per 100,000 live births and to only present during infancy or early childhood.<xref ref-type="ref" rid="mds27484-bib-0001">1</xref> We now know that this prevalence is an underestimate, and that IEM present in adolescence or adulthood much more often than previously thought. Retrospective data from an ethnically diverse population in the United Kingdom (1999‐2003) revealed an overall prevalence of metabolic disease of 1 per 784 live births; mitochondrial diseases, lysosomal storage diseases, and amino acid disorders were most frequent. Furthermore, more than one quarter of all diagnoses were made after the age of 15 years.<xref ref-type="ref" rid="mds27484-bib-0002">2</xref> Adult phenotypes may differ from the classic childhood‐onset phenotypes. In adulthood, many IEM patients present with neurological or psychiatric symptoms, but considering an IEM in the differential diagnosis of an adult patient is still uncommon among neurologists.<xref ref-type="ref" rid="mds27484-bib-0003">3</xref> Missing or delaying diagnosis of an IEM can have important implications. In particular, patients with a milder phenotype appear to benefit most from timely treatment, so identifying them is important to prevent further (neurological) damage.<xref ref-type="ref" rid="mds27484-bib-0004">4</xref>
</p>
<p>Whereas the neurological symptoms in patients with IEM often involve various types of movement disorders,<xref ref-type="ref" rid="mds27484-bib-0005">5</xref> eye movement disorders are also frequently observed and can be an important diagnostic clue.<xref ref-type="ref" rid="mds27484-bib-0006">6</xref> The type of eye movement disorder can often further delineate the type of IEM.</p>
<p>The aim of this article is to review the abnormalities of eye movements that can be observed in IEM, with an emphasis on those IEMs that can present later in life. Our goal is to increase awareness of eye movements in adult patients with movement disorders and other neurological or psychiatric disturbances because they can be the key to early diagnosis. Because more types of IEM are being identified that can be treated, early recognition of these disorders is important.</p>
<sec id="mds27484-sec-0002">
<title>Search Strategy and Selection Criteria</title>
<p>We reviewed articles regarding ocular motility disorders and IEM up to June 2017. References were identified by PubMed, text book search, and through citations in relevant articles and books. Only articles published in English were included. Search terms are in Supplementary Appendix I. Only IEMs with at least 2 patients with some type of eye movement disorder were included in the review. Although we focused on late‐onset IEM (adolescent‐onset 16‐18 years of age, adult‐onset &gt; 18 years of age), it is difficult to discriminate specifically between early‐ and late‐onset forms, given that eye movement disorders are frequently not described in the literature. For that reason, children were also included in this review. We included mitochondrial diseases as a combined disease group instead of specific subtypes. We excluded articles in which nystagmus secondary to blindness was the only ocular motor finding. Supplementary Appendix II presents a list of references with videos of eye movement disorders in IEM.</p>
</sec>
<sec id="mds27484-sec-0003">
<title>Examination of Eye Movements</title>
<p>Disorders of eye movement can be categorized as peripheral and central (Table <xref ref-type="table" rid="mds27484-tbl-0001">1</xref>). Peripheral eye movement disorders are particularly frequent in mitochrondrial disorders and commonly affect the two eyes differently, resulting in ocular misalignment and diplopia. Progressive external ophthalmoplegia (PEO) is an important exception to this rule.<xref ref-type="ref" rid="mds27484-bib-0007">7</xref> Because of the insidious onset and slow progression, patients do not complain of diplopia and may be unaware of any disorder of eye movements.<xref ref-type="ref" rid="mds27484-bib-0008">8</xref> Central causes of ocular motor abnormalities usually affect both eyes.<xref ref-type="ref" rid="mds27484-bib-0007">7</xref>, <xref ref-type="ref" rid="mds27484-bib-0009">9</xref>
</p>
<table-wrap id="mds27484-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Peripheral and central eye movement disorders</p>
</caption>
<table frame="hsides" rules="groups">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Anatomical Location</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Abnormality During Examination</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Peripheral origin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retina and optic nerve</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nystagmus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Ocular muscles, ocular nerves and nuclei (oculomotor, trochlear, abducens)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impaired range of motion, strabismus, abnormal smooth pursuit, saccades, vestibulo‐ocular reflex, and optokinetic nystagmus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Peripheral vestibular system</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nystagmus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Central origin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Central visual pathways and cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nystagmus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Cerebellum and brainstem</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impaired range of motion, abnormal smooth pursuit, saccades, vestibulo‐ocular reflex, and optokinetic nystagmus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Frontoparietal cortex, basal ganglia, and cerebellum</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oculomotor apraxia<xref ref-type="fn" rid="mds27484-note-0003">
<sup>a</sup>
</xref>, impaired smooth pursuit</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Basal ganglia and midbrain</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oculogyric crisis<xref ref-type="fn" rid="mds27484-note-0004">
<sup>b</sup>
</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="mds27484-note-0003">
<label>
<sup>a</sup>
</label>
<p>Oculomotor apraxia: failure of saccade initiation.</p>
</fn>
<fn id="mds27484-note-0004">
<label>
<sup>b</sup>
</label>
<p>Oculogyric crisis: episodes of tonic upward conjugate deviation of the eyes with an inability to look downward.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Clinical examination of the eye movements in all patients with a suspected IEM is essential. Patients themselves may not report visual symptoms or may only have nonspecific complaints.<xref ref-type="ref" rid="mds27484-bib-0009">9</xref>, <xref ref-type="ref" rid="mds27484-bib-0010">10</xref> Table <xref ref-type="table" rid="mds27484-tbl-0002">2</xref> provides a short step‐by‐step overview of the clinical examination of eye movements. Every step in the table needs to be followed because different types of eye movement disorders can exist in 1 patient.</p>
<table-wrap id="mds27484-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Seven‐step examination of eye movements (modified from both Leigh and Strupp<xref ref-type="ref" rid="mds27484-bib-0009">9</xref>, <xref ref-type="ref" rid="mds27484-bib-0010">10</xref>)</p>
</caption>
<table frame="hsides" rules="groups">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="bottom">Type of Examination</th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Abnormalities</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Step 1</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Inspection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Posture of head and neck</td>
<td align="left" colspan="1" rowspan="1" valign="top">Head turn or tilt in diplopia, gaze palsy, dystonia, or otolith disorders. Head thrusts in saccade initiation disorders (ocular motor apraxia)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Face and eyelids</td>
<td align="left" colspan="1" rowspan="1" valign="top">Blepharospasm, ptosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Step 2</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4" valign="top">Examination of vision, pupils, and fundus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Vision</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impaired visual acuity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Confrontation visual fields</td>
<td align="left" colspan="1" rowspan="1" valign="top">Visual field defect</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pupillary reflexes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Delayed or absent, light to near dissociation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fundus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pathology of the retina or optic nerve, subtle forms of nystagmus or saccadic oscillations</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Step 3</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fixation, range of motility, and alignment</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gaze in center and eccentric position, Vergence</td>
<td align="left" colspan="1" rowspan="1" valign="top">Limited range of motion of one or both eyes Strabismus (horizontal and vertical misalignment) Saccadic intrusions (square‐wave jerks) during fixation Gaze palsy Primary position or gaze‐evoked nystagmus Oculogyric crises</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Step 4</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Frenzel's spectacles to eliminate fixation or occlusive ophthalmoscopy (cover one eye while viewing the fundus of the other)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gaze in center and eccentric position</td>
<td align="left" colspan="1" rowspan="1" valign="top">Spontaneous nystagmus brought out by removal of fixation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Step 5</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Saccades</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rapidly changing gaze from one fixation point to another<break></break>
‐Spontaneous saccades<break></break>
‐Self‐generated saccades on<break></break>
‐command (look left‐right, up‐down)<break></break>
‐Saccades to specific targets (pen‐finger)<break></break>
‐Rapid self‐paced saccades between two specific targets<break></break>
‐Antisaccades (look at the mirror location in the opposite direction to the target when it appears or moves)
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impaired initiation: ocular motor apraxia Increased latency, decreased velocity, inaccuracy, or disconjugacy</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Step 6</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Optokinetic nystagmus and pursuit</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tracking a small, smoothly moving target in horizontal and vertical directions with head still or with head moving (vestibular suppression)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Corrective, catch‐up saccades (tracking with head still) or back‐up saccades (tracking with head moving) to reacquire the fixation target</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Optokinetic drum or tape in horizontal and vertical direction</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not inducible, direction asymmetry</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Step 7</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">Vestibulo‐ocular reflex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Head‐impulse test<xref ref-type="fn" rid="mds27484-note-0005">
<sup>a</sup>
</xref> (passive rapid turning of the head while fixation on a stationary target)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Corrective saccades instead of stable fixation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Head‐shaking test (oscillate head 20 times)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Post head shaking nystagmus in peripheral and in central vestibular disorders</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="mds27484-note-0005">
<label>
<sup>a</sup>
</label>
<p>The head impulse test maximizes the ability of the vestibular system to overcome a supranuclear palsy.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Video‐oculography (VOG) allows for better quantitative documentation of abnormalities. Typically, a digital camera mounted in goggles uses the contrast between the pupil and iris to track the movement and position of one or both of the eyes.<xref ref-type="ref" rid="mds27484-bib-0011">11</xref> VOG is an effective user‐ and patient‐friendly tool to quantify eye movements, including subtle changes in latency, velocity, and accurary of saccades.<xref ref-type="ref" rid="mds27484-bib-0012">12</xref> It can be used to support or make a diagnosis and measure effectiveness of treatment during follow‐up. For example, in Niemann‐Pick type C (NP‐C), saccadic parameters measured by VOG have been reported to be a robust indicator of efficacy of treatment with Miglustat.<xref ref-type="ref" rid="mds27484-bib-0013">13</xref>
</p>
</sec>
<sec id="mds27484-sec-0004">
<title>Inborn Errors of Metabolism Associated With Ocular Motor Disorders</title>
<p>We will discuss abnormalities of eye movements in IEM. An overview of the various IEMs associated with ocular motor disorders, including the underlying gene defect, metabolic abnormalities, age of onset, early‐onset symptoms, and treatment, is given in Table <xref ref-type="table" rid="mds27484-tbl-0003">3</xref>. Table <xref ref-type="table" rid="mds27484-tbl-0004">4</xref> presents the described eye movement disorders for each of those IEMs.</p>
<table-wrap id="mds27484-tbl-0003" orientation="portrait" position="float" xml:lang="en">
<label>Table 3</label>
<caption>
<p>Inborn errors of metabolism associated with eye movement abnormalities</p>
</caption>
<table frame="hsides" rules="groups">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Inheritance</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Functional Consequences</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Age of Onset</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Early‐Onset Symptoms</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Treatment</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Lysosomal storage diseases</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Niemann‐Pick type C</td>
<td align="left" colspan="1" rowspan="1" valign="top">NP‐C1, NP‐C2</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lipid accumulation in cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Early infantile‐adulthood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hepatosplenomegaly, neuropsychiatric symptoms later in life</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miglustat</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gaucher's disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">GBA</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Accumulation of glucosylceramide and the cytotoxic derivative of glucosylceramide</td>
<td align="left" colspan="1" rowspan="1" valign="top">Early infantile‐adulthood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Type 1: hepatosplenomegaly, bone anomalies, cytopenia Type 2: early death attributed to neurological symptoms Type 3: progressive encephalopathy and systemic symptoms</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miglustat, enzyme replacement therapy</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tay‐Sachs disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">HEXA</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Disturbance of catabolism and eventually accumulation of GM2 ganglioside, particularly in neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Usually infantile, sometimes late‐onset</td>
<td align="left" colspan="1" rowspan="1" valign="top">Early death attributed to psychomotor retardation, neurodegeneration, and muscle weakness Cherry‐red spot in the ocular fundus</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sandhoff's disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">HEXB</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Disturbance of catabolism and eventually accumulation of GM2 ganglioside, particularly in neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Usually infantile, sometimes late‐onset</td>
<td align="left" colspan="1" rowspan="1" valign="top">Early death attributed to psychomotor retardation, neurodegeneration, and muscle weakness Cherry‐red spot in the ocular fundus</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Disorders of lipid metabolism</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Abetalipoproteinemia</td>
<td align="left" colspan="1" rowspan="1" valign="top">MTTP</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impairment of the absorption of dietary fats, cholesterol, and fat‐soluble vitamins</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood, sometimes late‐onset</td>
<td align="left" colspan="1" rowspan="1" valign="top">Failure to thrive and growth failure, hepatomegaly with steatosis, diarrhea, ataxia</td>
<td align="left" colspan="1" rowspan="1" valign="top">High‐dose vitamin E, supplementation of vitamin A,D, and K, low‐fat diet</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cerebrotendinous xanthomatosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">CYP27A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cholesterol and cholestanol accumulation in cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood‐adulthood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Diarrhea, jaundice, premature cataracts, ataxia; xanthomata in the second or third decade</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chenodeoxycholic acid and statin therapy</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Disorders of carbohydrate metabolism</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Glucose transporter type 1 deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">SLC2A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">AD</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impairment of the transport of glucose from the blood to cerebral tissue</td>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile‐childhood, sometimes late‐onset</td>
<td align="left" colspan="1" rowspan="1" valign="top">Psychomotor retardation, seizures, microcephaly, spasticity, movement disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ketogenic diet</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Disorders of mineral, metal, and vitamin metabolism</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Wilson's disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">ATP7B</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Accumulation of copper, particularly in the liver and brain</td>
<td align="left" colspan="1" rowspan="1" valign="top">Early childhood‐adulthood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Liver disease, neurological and psychiatric symptoms, Kayser‐Fleischer ring</td>
<td align="left" colspan="1" rowspan="1" valign="top">Penicillamine, trientine, zinc</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Hypermanganesemia with dystonia 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">SLC30A10</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Accumulation of manganese in liver and basal ganglia</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood‐adolescence</td>
<td align="left" colspan="1" rowspan="1" valign="top">Severe dystonia and other movement disorders, liver dysfunction</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chelation therapy, iron supplementation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pantothenate kinase‐associated neurodegeneration</td>
<td align="left" colspan="1" rowspan="1" valign="top">PKAN2</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Accumulation of iron, especially in the globus pallidus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood‐adolescence</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dystonia, chorea, rigidity, dysarthria, pigmentary retinopathy, developmental delay</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Adult‐onset dystonia‐parkinsonism</td>
<td align="left" colspan="1" rowspan="1" valign="top">PLA2G6</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Accumulation of iron, especially in the globus pallidus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adulthood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Parkinsonism, dystonia, cognitive decline</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Biotin‐thiamine–responsive basal ganglia disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">SLC19A3</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impairment of thiamine uptake into cells, causing destruction of the head of the caudate and putamen</td>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile‐adolescence</td>
<td align="left" colspan="1" rowspan="1" valign="top">Acute dystonia, encephalopathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thiamine and biotin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ataxia with vitamin E deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">TTPA</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impairment of incorporation of vitamin E into very‐low‐density lipoprotein, leading to low plasma levels of vitamin E</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood‐adulthood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ataxia, areflexia, impaired proprioception</td>
<td align="left" colspan="1" rowspan="1" valign="top">Vitamin E</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Disorders of amino acid metabolism</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Maple syrup urine disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">BCKDHA, BCKDHB, DBT</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preventing the normal breakdown of leucine, isoleucine, and valine, leading to accumulation of these amino acids</td>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile, late‐onset presentation is rare</td>
<td align="left" colspan="1" rowspan="1" valign="top">Maple syrup odor in the cerumen and later in urine, poor feeding, progressive encephalopathy, intermittent apnea, stereotyped movements</td>
<td align="left" colspan="1" rowspan="1" valign="top">Low‐protein diet, leucine‐, isoleucine‐, and valine‐free amino acid supplement, emergency regimens</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Glutaric aciduria type 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">GCDH</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preventing the breakdown of lysine, hydroxylysine, and tryptophan, leading to accumulation of metabolites</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood‐adulthood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Acute encephalopathic crises, dystonia (with insidious onset)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Avoidance and treatment of triggers, dietary lysine restriction, L‐carnitine, emergency regimens</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Congenital disorders of glycosylation</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Phosphomannomutase 2 deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">PMM2</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Affecting glycoprotein biosynthesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood, sometimes late‐onset</td>
<td align="left" colspan="1" rowspan="1" valign="top">Developmental delay, hypotonia, ataxia, retinitis pigmentosa, strabismus, seizures, abnormal fat distribution</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Disorders of purine or pyrimidine metabolism</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lesch‐Nyhan syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">HPRT</td>
<td align="left" colspan="1" rowspan="1" valign="top">X‐linked recessive</td>
<td align="left" colspan="1" rowspan="1" valign="top">Affecting the breakdown of purines, leading to high levels of uric acid in blood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile‐adulthood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Severe dystonia and behavioral abnormalities, including self‐injury</td>
<td align="left" colspan="1" rowspan="1" valign="top">Treatment of hyperuricemia</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Peroxisomal disorders</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Zellweger spectrum disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">PEX genes</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Affecting the formation of functional peroxisomes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile, sometimes late‐onset</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypotonia, seizures, deafness, developmental delay, characteristic facial appearance, liver dysfunction</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Neurotransmitter disorders</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Aromatic L‐amino acid decarboxylase deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">DDC</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced production of dopamine, serotonin, and tryptamine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Usually infantile, sometimes late‐onset</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dystonia, psychomotor retardation, spasticity, autonomic dysfunction</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pyridoxine, dopamine agonists, and MAO‐inhibitors</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tyrosine hydroxylase deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">TH</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impairment of the conversion of L‐tyrosine to <sc>l</sc>‐dopa</td>
<td align="left" colspan="1" rowspan="1" valign="top">Usually infantile, sometimes late‐onset</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dystonia, mild intellectual deficit</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sc>l</sc>‐dopa</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GTP‐CH‐I deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">GCH1</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR or AD</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impairment of the tetrahydrobiopterin (BH4) biosynthesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile‐adolescence</td>
<td align="left" colspan="1" rowspan="1" valign="top">Psychomotor retardation, convulsions, drowsiness, abnormal movements, autonomic dysfunction</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sc>l</sc>‐dopa, 5‐hydroxytryptophan, and tetrahydrobiopterin (the latter two only in recessive forms)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sepiapterin reductase deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">SPR</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR (or AD?)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impairment of the tetrahydrobiopterin (BH4) biosynthesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">Usually infantile</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dystonia, psychomotor retardation, axial hypotonia, weakness</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sc>l</sc>‐dopa, 5‐hydroxytryptophan, and tetrahydrobiopterin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">6‐Pyruvoyl‐tetrahydropterin synthase deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">PTS</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impairment of the tetrahydrobiopterin (BH4) biosynthesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">Usually infantile, sometimes late‐onset</td>
<td align="left" colspan="1" rowspan="1" valign="top">Psychomotor retardation, convulsions, drowsiness, abnormal movements, autonomic dysfunction</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sc>l</sc>‐dopa, 5‐hydroxytryptophan, and tetrahydrobiopterin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Brain dopamine‐serotonin vesicular transport disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">SLC18A2</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impairment of the monoamine transport in synaptic vesicles</td>
<td align="left" colspan="1" rowspan="1" valign="top">Usually infantile, sometimes late‐onset</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dystonia‐parkinsonism, autonomic dysfunction, developmental delay</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine agonists</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine transporter deficiency syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">SLC6A3</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Loss of function of the presynaptic dopamine transporter</td>
<td align="left" colspan="1" rowspan="1" valign="top">Usually infantile</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dystonia‐parkinsonism, developmental delay</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Energy metabolism disorders</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mitochondrial diseases</td>
<td align="left" colspan="1" rowspan="1" valign="top">Multiple genes</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR, AD, X‐linked</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impairment of the respiratory chain or oxidative phosphorylation system</td>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile‐adulthood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wide range of symptoms, including movement disorders, psychomotor retardation or regression, epilepsy, muscle weakness, migraine</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pyruvate dehydrogenase E2 deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">DLAT</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Accumulation of pyruvate in cells, resulting in production of lactic acid and alanine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Usually infantile, sometimes late‐onset</td>
<td align="left" colspan="1" rowspan="1" valign="top">Severe neonatal lactic acidosis, leading to death, dystonia</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ketogenic diet, thiamine, triheptanoin</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="mds27484-tbl-0004" orientation="portrait" position="float" xml:lang="en">
<label>Table 4</label>
<caption>
<p>Abnormalities of eye movements in inborn errors of metabolism</p>
</caption>
<table frame="hsides" rules="groups">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<thead valign="bottom">
<tr>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="center" colspan="3" rowspan="1" style="border-bottom:solid 1px #000000" valign="bottom">Impaired Saccades
</th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Ptosis</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Impaired Vision</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Oculogyric Crisis</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Nystagmus</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Saccadic Oscillations (Flutter and Opsoclonus)</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">
<italic>Paralysis</italic>
</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">
<italic>Dysmetric</italic>
</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">
<italic>Slow</italic>
</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Ocular Motor Apraxia (Saccade Initiation Deficit)</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Impaired Smooth Pursuit</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Impaired Optokinetic Nystagmus</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Impaired Vestibulo‐ ocular Reflex</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Estimated Prevalence of Eye Movement Disorders</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Lysosomal storage diseases</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Niemann‐Pick type C</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x(V)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Gaucher's disease type 1</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">?</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Gaucher's disease type 2</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Gaucher's disease type 3</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x(H)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Tay‐Sachs disease, infantile form</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x(V)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+/–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Tay‐Sachs disease, late‐onset form</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x(V)</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+/–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Sandhoff's disease</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">?</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Disorders of lipid metabolism</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Abetalipoproteinemia</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Cerebrotendinous xanthomatosis</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+/–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Disorders of carbohydrate metabolism</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Glucose transporter type 1 deficiency</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Disorders of mineral, metal, and vitamin metabolism</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Wilson's disease</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x(V)</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Hypermanganesemia with dystonia 1</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">?</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Pantothenate kinase‐associated neurodegeneration</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">+/–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Adult‐onset dystonia‐parkinsonism</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x(V)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+/–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Biotin‐thiamine–responsive basal ganglia disease</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x(V)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">?</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Ataxia with vitamin E deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Disorders of amino acid metabolism</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Maple syrup urine disease</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">+/–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Glutaric aciduria type 1</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x(V)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+/–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Congenital disorders of glycosylation</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Phosphomannomutase 2 deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Disorders of purine or pyrimidine metabolism</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Lesch‐Nyhan syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+/–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Peroxisomal disorders</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Zellweger spectrum disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Neurotransmitter disorders</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Dopamine transporter deficiency syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Other disorders of dopamine synthesis or transport<xref ref-type="fn" rid="mds27484-note-0007">
<sup>a</sup>
</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">+/–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Energy metabolism disorders</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Mitochondrial diseases</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x(PEO)</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="center" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%" valign="top">Pyruvate dehydrogenase E2 deficiency</td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x(V)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">x</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">?</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="mds27484-note-0006">
<p>x: Present.</p>
</fn>
<fn id="mds27484-note-0007">
<label>
<sup>a</sup>
</label>
<p>Aromatic L‐amino acid decarboxylase deficiency, tyrosine hydroxylase deficiency, GTP‐CH‐I deficiency (dominant and recessive), sepiapterin reductase deficiency, 6‐pyruvoyl‐tetrahydropterin synthase deficiency, brain dopamine‐serotonin vesicular transport disease.</p>
</fn>
<fn id="mds27484-note-0008">
<p>(V): Primarily vertical. (H): Primarily horizontal. (PEO): Progressive external ophthalmoplegia.</p>
</fn>
<fn id="mds27484-note-0009">
<p>+: frequent. + /–: infrequent. ?: unknown.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="mds27484-sec-0005">
<title>Lysosomal Storage Diseases</title>
<p>Late‐onset NP‐C usually presents with neurological problems. Movement disorders are frequent, particularly in these adolescent‐ and adult‐onset forms.<xref ref-type="ref" rid="mds27484-bib-0014">14</xref> Eye movement disorders are also an important feature. Vertical supranuclear gaze palsy (VSGP) is a key feature and is present in approximately 65% of patients.<xref ref-type="ref" rid="mds27484-bib-0015">15</xref> VSGP in patients with NP‐C is characterized by a paralysis of vertical (especially downward) saccades, whereas smooth pursuit is initially spared.<xref ref-type="ref" rid="mds27484-bib-0016">16</xref> Horizontal saccades are initially preserved, but are ultimately affected as the disease progresses.<xref ref-type="ref" rid="mds27484-bib-0017">17</xref>, <xref ref-type="ref" rid="mds27484-bib-0018">18</xref> A so‐called round‐the‐houses phenomenon occurs when attempting vertical saccades: The eyes do not move directly up and down, but in a lateral arc (Video 1).<xref ref-type="ref" rid="mds27484-bib-0016">16</xref>, <xref ref-type="ref" rid="mds27484-bib-0019">19</xref> A similar phenomenon occurs during horizontal saccades in Gaucher's disease. No abnormalities of vestibulo‐ocular responses have been found.<xref ref-type="ref" rid="mds27484-bib-0020">20</xref> Treatment is possible with Miglustat.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>
</p>
<p>Gaucher's disease type 2 (acute neurological form) and type 3 (subacute neurological form) are the neuronopathic forms of this lysosomal storage disorder. Gaucher's disease type 2 presents during infancy and abnormalities of eye movements are early signs in affected children, including ocular motor paralysis, slowness of saccades, oculomotor “apraxia,” and strabismus.<xref ref-type="ref" rid="mds27484-bib-0022">22</xref>, <xref ref-type="ref" rid="mds27484-bib-0023">23</xref> Gaucher's disease type 3 presents during childhood or adolescence. Movement disorders are common in type 3, particularly ataxia and parkinsonism.<xref ref-type="ref" rid="mds27484-bib-0024">24</xref> However, patients often present with (myoclonus) epilepsy and supranuclear gaze palsy that only affects horizontal gaze.<xref ref-type="ref" rid="mds27484-bib-0025">25</xref>, <xref ref-type="ref" rid="mds27484-bib-0026">26</xref>, <xref ref-type="ref" rid="mds27484-bib-0027">27</xref> Horizontal saccades are markedly slow and may show a curved trajectory, whereas vertical saccades are initially preserved.<xref ref-type="ref" rid="mds27484-bib-0028">28</xref>, <xref ref-type="ref" rid="mds27484-bib-0029">29</xref>, <xref ref-type="ref" rid="mds27484-bib-0030">30</xref> Vestibulo‐ocular responses may be impaired.<xref ref-type="ref" rid="mds27484-bib-0031">31</xref> Ocular motor apraxia, which in fact reflects abnormal patterns of head motion associated with defects in initiation of saccades, is also observed in Gaucher's types 2 and 3.<xref ref-type="ref" rid="mds27484-bib-0030">30</xref>, <xref ref-type="ref" rid="mds27484-bib-0032">32</xref> Similar to NP‐C, patterns of abnormal saccades can be used to monitor progression of disease.<xref ref-type="ref" rid="mds27484-bib-0009">9</xref>, <xref ref-type="ref" rid="mds27484-bib-0033">33</xref> Gaucher's disease type 1 is the chronic non‐neurological form; however, subtle slowness of saccades has been reported in some patients.<xref ref-type="ref" rid="mds27484-bib-0022">22</xref>, <xref ref-type="ref" rid="mds27484-bib-0034">34</xref>, <xref ref-type="ref" rid="mds27484-bib-0035">35</xref>, <xref ref-type="ref" rid="mds27484-bib-0036">36</xref> Enzyme replacement therapy and substrate reduction therapy are available.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>
</p>
<p>In the late‐onset form of Tay‐Sachs disease (GM2 gangliosidosis), motor symptoms are frequent. These are caused by motor neuron dysfunction and cerebellar involvement with ataxia.<xref ref-type="ref" rid="mds27484-bib-0037">37</xref> Abnormalities of eye movements are not a classic feature of late‐onset Tays‐Sachs disease, but impaired smooth pursuit with square‐wave jerks (saccadic intrusions), transient decelerations of saccades, and up‐gaze palsy have been described. Vestibulo‐ocular responses are normal.<xref ref-type="ref" rid="mds27484-bib-0037">37</xref>, <xref ref-type="ref" rid="mds27484-bib-0038">38</xref>, <xref ref-type="ref" rid="mds27484-bib-0039">39</xref>, <xref ref-type="ref" rid="mds27484-bib-0040">40</xref> In early‐onset Tach‐Sachs disease, vertical gaze is impaired early and horizontal gaze later in the disease.<xref ref-type="ref" rid="mds27484-bib-0009">9</xref> Treatment is not available.</p>
<p>The clinical picture of Sandhoff's disease (GM2 gangliosidosis) is similar to Tay‐Sachs disease. Early childhood forms are most common. Late‐onset forms of Sandhoff's disease are rare and have a milder phenotype. They often present as a complex neurological disorder with ataxia, chorea, tremor, dystonia, or parkinsonism in combination with motor neuron dysfunction.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref> Abnormalities of eye movements include impaired horizontal and vertical saccades with nystagmus.<xref ref-type="ref" rid="mds27484-bib-0041">41</xref>, <xref ref-type="ref" rid="mds27484-bib-0042">42</xref>, <xref ref-type="ref" rid="mds27484-bib-0043">43</xref> A patient with adult‐onset Sandhoff's disease and pendular nystagmus in combination with palatal tremor has been described.<xref ref-type="ref" rid="mds27484-bib-0041">41</xref> Treatment is not available.</p>
</sec>
<sec id="mds27484-sec-0006">
<title>Disorders of Lipid Metabolism</title>
<p>Signs of <italic>abetalipoproteinemia</italic> occur early in life and progress with time. Neurological manifestations resulting from vitamin deficiency often begin in the first or second decade of life. Low vitamin E in particular can cause progressive neurological symptoms affecting the peripheral and central nervous system. Adult patients show malabsorption, steatosis, abnormal liver transaminases, and neurological signs.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref> Abnormalities of eye movements are typical, including progressive gaze disturbances attributed to paresis of the medial rectus muscles and a characteristic pattern of dissociated nystagmus. The latter consists of an intense nystagmus, but with limited range in the adducting eye, and a less‐intense nystagmus, but with full range, in the abducting eye. Patients complain of trouble reading and of difficulties associated with impaired convergence. Saccades are slow and hypometric. Vestibular nystagmus and optokinetic nystagmus have abnormal or absent quick phases.<xref ref-type="ref" rid="mds27484-bib-0044">44</xref> A low‐fat diet with reduced long‐chain fatty acids and fat‐soluble vitamin supplements is recommended.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>
</p>
<p>Late‐onset cerebrotendinous xanthomatosis is characterized by tendon xanthomas, psychiatric symptoms, and neurological symptoms, including pyramidal, cerebellar, and extrapyramidal signs in the second or third decade of life.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>, <xref ref-type="ref" rid="mds27484-bib-0045">45</xref> Patients show abnormal pursuit, increased saccadic intrusions, multistep saccades, and antisaccade deficits.<xref ref-type="ref" rid="mds27484-bib-0046">46</xref> Chenodeoxycolic acid and statin therapy are an effective treatment and can prevent neurological involvement if started early.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>, <xref ref-type="ref" rid="mds27484-bib-0047">47</xref>, <xref ref-type="ref" rid="mds27484-bib-0048">48</xref>
</p>
</sec>
<sec id="mds27484-sec-0007">
<title>Disorders of Carbohydrate Metabolism</title>
<p>Symptoms of glucose transporter type 1 deficiency usually occur early in life, but may present in adolescence or adulthood. In the late presentation form, paroxysmal exercise‐induced dyskinesia occurs that predominantly manifests as dystonia, chorea, and ballism. Epilepsy is also observed.<xref ref-type="ref" rid="mds27484-bib-0049">49</xref> Abnormalities of eye movements are common and may be highly characteristic brief multidirectional paroxysmal episodes of rapid eye movements in combination with head movements in the same direction, a phenomenon called aberant gaze saccades.<xref ref-type="ref" rid="mds27484-bib-0050">50</xref> Eye rolling and fluttering, strabismus, opsoclonus, and limitation of vertical eye movements have also been described.<xref ref-type="ref" rid="mds27484-bib-0050">50</xref>, <xref ref-type="ref" rid="mds27484-bib-0051">51</xref>, <xref ref-type="ref" rid="mds27484-bib-0052">52</xref> Early diagnosis is important because this disorder can be treated with a ketogenic diet.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>
</p>
</sec>
<sec id="mds27484-sec-0008">
<title>Disorders of Mineral, Metal, or Vitamin Metabolism</title>
<p>Symptoms of Wilson's disease often begin in the teenage years. Liver disease is frequently the presenting sign, but psychiatric and neurological symptoms including movement disorders are also frequent presentations. The Kayser‐Fleischer ring, copper deposits that form a ring in the cornea, is the ophthalmological hallmark of Wilson's disease.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref> Abnormalities of eye movements are frequently present. Impaired vertical, but sometimes also horizontal pursuit, selective slowing of downward saccades, and dysmetria of saccades are all reported.<xref ref-type="ref" rid="mds27484-bib-0053">53</xref>, <xref ref-type="ref" rid="mds27484-bib-0054">54</xref>, <xref ref-type="ref" rid="mds27484-bib-0055">55</xref>, <xref ref-type="ref" rid="mds27484-bib-0056">56</xref>, <xref ref-type="ref" rid="mds27484-bib-0057">57</xref> Gaze distractibility has also been described in which patients cannot fix their eyes on a stationary or moving object for more than a few seconds without being distracted by other stimuli.<xref ref-type="ref" rid="mds27484-bib-0058">58</xref> At least 1 patient with oculogyric crises has been reported on.<xref ref-type="ref" rid="mds27484-bib-0059">59</xref> Treatment is possible with chelation therapy.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>
</p>
<p>Adult‐onset hypermanganesemia with dystonia 1 is characterized by parkinsonism, whereas children usually present with dystonia. Bilateral hyperintensities in the basal ganglia and white matter attrobuted to accumulation of manganese are typically observed on brain imaging.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref> Increased latency of saccades, misdirected antisaccades, and multistep saccades have been observed by one of the authors (A.R., personal observations). Chelation therapy and iron supplementation are recommended<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>.</p>
<p>Pantothenate kinase‐associated neurodegeneration (or NBIA type 1) is the most common form of neurodegeneration with brain iron accumulation (NBIA). This is reflected in the “eye‐of‐the‐tiger” sign on brain MRI.<xref ref-type="ref" rid="mds27484-bib-0060">60</xref> Late‐onset disease occurs during the second or third decade. It is slowly progressive and is characterized by speech problems, movement disorders, and psychiatric symptoms.<xref ref-type="ref" rid="mds27484-bib-0061">61</xref> Horizontal and vertical supranuclear gaze palsy, impaired saccades, abnormal optokinetic nystagmus, and impaired horizontal vestibulo‐ocular responses have been described.<xref ref-type="ref" rid="mds27484-bib-0062">62</xref>, <xref ref-type="ref" rid="mds27484-bib-0063">63</xref> Oculogyric crisis has been reported in 1 patient.<xref ref-type="ref" rid="mds27484-bib-0060">60</xref> Treatment with chelation therapy is not effective.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>
</p>
<p>Adult‐onset dystonia‐parkinsonism (NBIA type 2) also belongs to the heterogeneous group of degenerative disorders causing iron accumulation. Adults usually present before the age of 30 and have parkinsonism, dystonia and cognitive decline. Ophthalmic features include strabismus, up‐gaze palsy, impaired pursuit with saccadic intrusions, and pendular nystagmus. Vestibulo‐ocular responses are not impaired.<xref ref-type="ref" rid="mds27484-bib-0064">64</xref> A case of oculogyric crisis induced by levodopa has been described in a patient with adult‐onset dystonia‐parkinsonism.<xref ref-type="ref" rid="mds27484-bib-0065">65</xref> Only symptomatic treatment is available.</p>
<p>The onset of biotin‐thiamine‐responsive basal ganglia disease is usually during early childhood, but can occur later in life.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>, <xref ref-type="ref" rid="mds27484-bib-0066">66</xref> In addition to acute dystonia and encephalopathy, bilateral external ophthalmoplegia is observed.<xref ref-type="ref" rid="mds27484-bib-0067">67</xref>, <xref ref-type="ref" rid="mds27484-bib-0068">68</xref>, <xref ref-type="ref" rid="mds27484-bib-0069">69</xref> Diagnosis is important because treatment with thiamine and biotin can be life‐saving.</p>
<p>Finally, onset of ataxia with vitamin E deficiency can be at any age. Symptoms include ataxia, areflexia, and impaired proprioception. Nystagmus is observed as part of a cerebellar syndrome. Impaired smooth pursuit, slow saccades, ocular motor apraxia, and strabismus have been reported.<xref ref-type="ref" rid="mds27484-bib-0009">9</xref>, <xref ref-type="ref" rid="mds27484-bib-0070">70</xref>, <xref ref-type="ref" rid="mds27484-bib-0071">71</xref>, <xref ref-type="ref" rid="mds27484-bib-0072">72</xref> Treatment is with high‐dose vitamin E supplementation.<xref ref-type="ref" rid="mds27484-bib-0072">72</xref>
</p>
</sec>
<sec id="mds27484-sec-0009">
<title>Disorders of Amino Acid Metabolism</title>
<p>Four clinical subtypes of maple syrup urine disease (MSUD) are described. Classic MSUD presents soon after birth and is a severe and often rapidly lethal disorder. The phenotypes of the other subtypes (intermediate, intermittent, and thiamine‐responsive MSUD) are overlapping. Presentation in adulthood is very rare. Patients with MSUD may decompensate during catabolic states and develop behavioral changes, nausea, vomiting, and eventually coma attributed to cerebral edema. Movement disorders may also be present.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref> Abnormalities of eye movements are described in infants and vary from up‐gaze palsy and adduction weakness to absence of voluntary eye movements with absent vestibulo‐ocular reflexes.<xref ref-type="ref" rid="mds27484-bib-0073">73</xref>, <xref ref-type="ref" rid="mds27484-bib-0074">74</xref>, <xref ref-type="ref" rid="mds27484-bib-0075">75</xref> Treatment is with a low‐protein diet in combination with a leucine‐, isoleucine‐, and valine‐free amino acid supplement. Emergency treatment is necessary during metabolic stress, such as intercurrent illnesses.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>
</p>
<p>Glutaric aciduria type 1 (GA1) usually begins in childhood, but adult‐onset has been reported as well. Catabolic episodes and intercurrent illnesses result in damage to the caudate nucleus and putamen, causing severe dystonia.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref> Ocular abnormalities include intraretinal haemorrhages, cataract, and pigmentary retinopathy.<xref ref-type="ref" rid="mds27484-bib-0076">76</xref> A 19‐year‐old woman with GA1 showed horizontal nystagmus, upward gaze palsy, and paralysis of convergence.<xref ref-type="ref" rid="mds27484-bib-0077">77</xref> Other patients with gaze palsy have been described, but gaze palsy in these patients might be secondary to increased intracranial pressure attributed to the intracranial haemorrhages that may be present in GA1.<xref ref-type="ref" rid="mds27484-bib-0076">76</xref> Dietary treatment with a low‐lysine diet and carnitine supplementation prevents damage to the striatum. Similar to MSUD, emergency treatment is necessary to prevent catabolism during periods of fever or prolonged fasting.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>
</p>
</sec>
<sec id="mds27484-sec-0010">
<title>Congenital Disorders of Glycosylation</title>
<p>Phosphomannomutase 2 deficiency (PMM2‐CDG or CDG1A) is the most common congenital disorder of glycosylation. The phenotype is variable, and multiple organs can be involved.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref> PMM2‐CDG is usually diagnosed in childhood, but attenuated forms present later. In adulthood, the symptoms may be mild and include ataxia and learning difficulties.<xref ref-type="ref" rid="mds27484-bib-0078">78</xref> A whole range of ocular manifestations can occur and include strabismus, impaired smooth pursuit, nystagmus, ocular flutter, ocular motor apraxia, impaired optokinetic nystagmus, and impaired vestibulo‐ocular reflexes.<xref ref-type="ref" rid="mds27484-bib-0079">79</xref>, <xref ref-type="ref" rid="mds27484-bib-0080">80</xref>, <xref ref-type="ref" rid="mds27484-bib-0081">81</xref>, <xref ref-type="ref" rid="mds27484-bib-0082">82</xref> Strabismus and nystagmus might be secondary to visual impairment, although they are also described in patients with PMM2‐CDG who have normal vision.<xref ref-type="ref" rid="mds27484-bib-0078">78</xref>, <xref ref-type="ref" rid="mds27484-bib-0082">82</xref> Other subtypes of congenital disorders of glycosylation 1 are less common, but some of these patients also show strabismus and nystagmus.<xref ref-type="ref" rid="mds27484-bib-0082">82</xref> With the exception of a few subtypes of CDG syndromes, treatment is not available.</p>
</sec>
<sec id="mds27484-sec-0011">
<title>Disorders of Purine or Pyrimidine Metabolism</title>
<p>Variants of Lesch Nyhan syndrome are described that present in early adulthood with symptoms of hyperuricemia, for example, nephrolithiasis, crystalluria, and gout.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref> Ocular motor abnormalities are observed particularly in severe (early‐onset) HPRT deficiency and include impaired smooth pursuit and difficulty initiating voluntary saccades that appears as an ocular motor apraxia.<xref ref-type="ref" rid="mds27484-bib-0083">83</xref> Hyperuricemia must be treated.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>
</p>
</sec>
<sec id="mds27484-sec-0012">
<title>Peroxisomal Disorders</title>
<p>In patients suffering from Zellweger spectrum disorders, three different presentations can be observed: a neonatal‐infantile, a childhood, and an adolescent‐adult presentation. The majority of patients presents in childhood.<xref ref-type="ref" rid="mds27484-bib-0084">84</xref> The phenotype is milder when the disease begins in adolescents or adults. Patients have mild‐to‐severe cognitive impairment in combination with retinal dystrophy, cataract, glaucoma, hearing impairment, ataxia, pyramidal symptoms, or peripheral neuropathy.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref> Vision is frequently impaired.<xref ref-type="ref" rid="mds27484-bib-0084">84</xref> Ocular motor abnormalities include hypometric saccades (particularly in the horizontal plane), saccadic intrusions (square‐wave jerks), and gaze‐evoked nystagmus.<xref ref-type="ref" rid="mds27484-bib-0085">85</xref> Pendular nystagmus can be observed.<xref ref-type="ref" rid="mds27484-bib-0086">86</xref> No curative treatment is available.</p>
</sec>
<sec id="mds27484-sec-0013">
<title>Neurotransmitter disorders</title>
<p>Disorders of neurotransmitters, especially those that affect the dopaminergic pathways, can cause dystonia with oculogyric crises. Response to low doses of <sc>l</sc>‐dopa in some of these diseases is excellent. Neurotransmitter disorders can be divided into those affecting synthesis, those affecting dopamine transport, and those affecting degradation.</p>
<p>Oculogyric crisis is frequently observed in disorders affecting dopamine synthesis, whereas other abnormalties of eye movements are rare in these disorders.<xref ref-type="ref" rid="mds27484-bib-0087">87</xref> Many of these disorders present early in life and, for most of the neurotransmitter disorders, late‐onset presentation is rare. Patients with milder forms of these disorders may remain undiagnosed until adolescence or adulthood, or may be mistakenly diagnosed with cerebral palsy.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref> However, recognition of these disorders is important because patients can improve dramatically when treated properly. Most of the late‐onset neurotransmitter disorders are caused by autosomal dominant GTP‐CH‐I deficiency. Patients present with dystonia of the lower limbs that usually progresses to generalized dystonia, although the late‐onset form can also be associated with parkinsonism.<xref ref-type="ref" rid="mds27484-bib-0088">88</xref> Autosomal recessive forms of GTP‐CH‐I deficiency have also been described. Oculogyric crises are more frequent in recessive than dominant forms of GTP‐CH‐I deficiency.<xref ref-type="ref" rid="mds27484-bib-0089">89</xref>, <xref ref-type="ref" rid="mds27484-bib-0090">90</xref>, <xref ref-type="ref" rid="mds27484-bib-0091">91</xref> Patients with aromatic L‐amino acid decarboxylase deficiency (AADC),<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>, <xref ref-type="ref" rid="mds27484-bib-0092">92</xref> tyrosine hydroxylase deficiency,<xref ref-type="ref" rid="mds27484-bib-0093">93</xref>, <xref ref-type="ref" rid="mds27484-bib-0094">94</xref>, <xref ref-type="ref" rid="mds27484-bib-0095">95</xref>, <xref ref-type="ref" rid="mds27484-bib-0096">96</xref> and 6‐pyruvoyl‐tetrahydropterin synthase deficiency<xref ref-type="ref" rid="mds27484-bib-0097">97</xref>, <xref ref-type="ref" rid="mds27484-bib-0098">98</xref> may show oculogyric crisis, in particular in AADC in which oculogyric crisis is one of the key features.<xref ref-type="ref" rid="mds27484-bib-0092">92</xref>, <xref ref-type="ref" rid="mds27484-bib-0099">99</xref>, <xref ref-type="ref" rid="mds27484-bib-0100">100</xref> Finally, oculogyric crisis is also described in sepiapterin reductase deficiency.<xref ref-type="ref" rid="mds27484-bib-0101">101</xref>, <xref ref-type="ref" rid="mds27484-bib-0102">102</xref>, <xref ref-type="ref" rid="mds27484-bib-0103">103</xref>
</p>
<p>Disorders affecting dopamine transport include brain dopamine‐serotonin vesicular disease (vesicular monoamine transporter 2 deficiency) and dopamine transporter deficiency syndrome (DAT deficiency). In the latter, adult onset is reported with parkinsonism and psychiatric symptoms.<xref ref-type="ref" rid="mds27484-bib-0104">104</xref> Both disorders are associated with oculogyric crisis.<xref ref-type="ref" rid="mds27484-bib-0087">87</xref>, <xref ref-type="ref" rid="mds27484-bib-0105">105</xref>, <xref ref-type="ref" rid="mds27484-bib-0106">106</xref> Other abnormalities of eye movements are also observed in DAT deficiency, including saccadic intrusions during smooth pursuit, saccadic oscillations (ocular flutter), slow saccadic eye movements, and ocular motor apraxia.<xref ref-type="ref" rid="mds27484-bib-0087">87</xref>, <xref ref-type="ref" rid="mds27484-bib-0104">104</xref>, <xref ref-type="ref" rid="mds27484-bib-0107">107</xref>
</p>
</sec>
<sec id="mds27484-sec-0014">
<title>Energy Metabolism Disorders</title>
<p>Mitochondrial diseases are a group of disorders caused by mutations in mitochondrial DNA (mtDNA; either maternally inherited or de novo) or nuclear DNA (Mendelian inherited). Tissues with high energy needs are commonly affected, including brain, heart, and skeletal muscles. There is a wide range of clinical phenotypes, and onset varies widely. Neurological involvement causes movement disorders, psychomotor retardation or regression, epilepsy, muscle weakness, and migraine.<xref ref-type="ref" rid="mds27484-bib-0108">108</xref> Adult onset of mitochondrial disease is especially frequent in disorders caused by multiple deletions in mtDNA, probably attributed to accumulation of mtDNA defects.<xref ref-type="ref" rid="mds27484-bib-0108">108</xref> Ocular involvement is frequent, and both central and peripheral causes of eye movements can be present. A well‐known form of ocular motor dysfunction in mitochondrial disease is PEO, characterized by progressive bilateral ptosis and weakness of the extraocular muscles. PEO often occurs in association with other symptoms.<xref ref-type="ref" rid="mds27484-bib-0109">109</xref> When it is the sole feature, it is called chronic PEO. PEO is seen in Kearn‐Sayre's syndrome, Pearson's syndrome, and multiple disorders attributed to mitochondrial deletions or point mutations.<xref ref-type="ref" rid="mds27484-bib-0110">110</xref> In mitochondrial neurogastrointestinal encephalomyopathy, PEO is characterized by slow and hypometric saccades, particularly for saccades larger than 10 degrees, and abducting saccades are slower than adducting saccades.<xref ref-type="ref" rid="mds27484-bib-0111">111</xref> Central eye movement disorders are observed in patients with Leigh's syndrome (subacute necrotizing encephalomyelopathy). Patients with early‐onset disease show disorders similar to those attributed to thiamine deficieny, including gaze‐evoked nystagmus, impaired vestibular responses, internuclear ophthalmoplegia, and upbeat nystagmus switching to downbeat nystagmus during convergence.<xref ref-type="ref" rid="mds27484-bib-0009">9</xref>, <xref ref-type="ref" rid="mds27484-bib-0112">112</xref> A combination of PEO with central eye movement disorders has been described in POLG‐related disorders. The phenotype of POLG‐related disorders is variable; it ranges from severe and often lethal childhood forms to later‐onset forms with a continuum of overlapping phenotypes, including ophthalmoplegia.<xref ref-type="ref" rid="mds27484-bib-0113">113</xref> In addition to ophthalmoplegia, ptosis, gaze‐evoked nystagmus, rebound nystagmus, abnormalties of saccades (dysmetria and slowing), and impaired pursuit have been observed.<xref ref-type="ref" rid="mds27484-bib-0114">114</xref> Treatment of mitochondrial diseases is still limited and includes vitamins and cofactors.<xref ref-type="ref" rid="mds27484-bib-0021">21</xref>
</p>
<p>Pyruvate dehydrogenase deficiency is divided into different subtypes. An adult patient diagnosed with pyruvate dehydrogenase E1 deficiency showed parkinsonism, impaired up gaze, and jerky horizontal eye movements during pursuit.<xref ref-type="ref" rid="mds27484-bib-0115">115</xref> Pendular nystagmus, eye rolling, and ocular motor apraxia are reported in children with pyruvate dehydrogenase E2 deficiency.<xref ref-type="ref" rid="mds27484-bib-0116">116</xref> The disease can be treated with a ketogenic diet, thiamine, L‐carnitine, and α‐lipoic acid.<xref ref-type="ref" rid="mds27484-bib-0117">117</xref>
</p>
</sec>
</sec>
<sec id="mds27484-sec-0015">
<title>Conclusions</title>
<p>We have reviewed IEM in which the onset of symptoms can occur relatively late in life and in which ocular motor abnormalities can be a prominent sign. Recognition of these patterns of abnormalities of eye movements is important because they may be the key to accurate early diagnosis and thus to a timely start of treatment. Unfortunately, there continues to be a lack of information about eye movement disorders in many IEMs because little attention is given to them in daily practice. Examination of the vestibular system, in particular, is neglected in most studies even though it often provides essential information about localization and diagnosis. Disorders of hearing are commonly recognized in many IEMs, but vestibular function is rarely commented upon. A standard, focused examination of the different subtypes of eye movements (range of motion, gaze‐holding, saccades, pursuit, and vestibular responses) can be performed relatively quickly in most patients during routine physical examination. Testing with video‐oculography has also become more user‐ and patient‐friendly and helps to quantify the eye movement abnormalities, making these abnormalities a valuable biomarker for following the natural course of disease or the response to therapies.</p>
</sec>
<sec id="mds27484-sec-0017" sec-type="note-added-in-proof">
<title>Author Roles</title>
<p>(1) Research Project: A. Conception, B. Organization, C. Execution; (2) Statistical Analysis: A. Design, B. Execution, C. Review and Critique; (3) Manuscript Preparation: A. Writing of the First Draft, B. Review and Critique.</p>
<p>L.H.K.: 1A, 1B, 1C, 3A, 3B</p>
<p>M.A.J.T.: 1A, 1B, 3B</p>
<p>F.L.: 3B</p>
<p>B.H.R.W.: 3B</p>
<p>A.R.: 1C, 3B</p>
<p>D.S.Z.: 1C, 3B</p>
<p>T.J.d.K.: 1A, 1B, 3B</p>
</sec>
<sec id="mds27484-sec-0018" sec-type="note-added-in-proof">
<title>Financial Disclosures</title>
<p>M.A.J.T. reports grants from Dystonia Medical Research Foundation, grants from Stichting Wetenschapsfonds Dystonie Vereniging, grants from Prinses Beatrix Foundation, grants from Fonds NutsOhra, from Jacques and Gloria Gossweiler Foundation, grants from Fonds Psychische Gezondheid, grants from Phelps Stichting, and grants from Ipsen &amp; Allergan Farmaceutics, Merz, Medtronic, and Actelion. D.S.Z. reports book royalties from Oxford University Press and honoraria for teaching in vestibular educational courses sponsored by Micromedical Technology. T.J.d.K. reports grants from Metabolic Power Foundation, grants from Friends of Beatrix Childrens Hospital, grants from Actelion pharmaceuticals, personal fees from Actelion pharmaceuticals, and personal fees from Nutricia Medical Nutrition.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data">
<caption>
<p>Supporting Information Appendix S1</p>
</caption>
<media xlink:href="MDS-33-1844-s001.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data">
<caption>
<p>Supporting Information Appendix S2</p>
</caption>
<media xlink:href="MDS-33-1844-s002.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data">
<caption>
<p>Video 1 (published before in Leigh)9:</p>
<p>This 25‐year‐old woman presented with an 8‐year history of progressive imbalance due to Niemann‐Pick type C disease. Horizontal saccades were relatively normal but, as shown in this video, vertical saccades were slow (especially downward) and showed curved trajectories.</p>
</caption>
<media xlink:href="MDS-33-1844-s003.mpg">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="mds27484-sec-0016">
<title>Acknowledgments</title>
<p>The authors thank Kate McIntyre, editor of the Department of Genetics, for editing the manuscript.</p>
</ack>
<ref-list content-type="cited-references">
<title>References</title>
<ref id="mds27484-bib-0001">
<label>1</label>
<mixed-citation id="mds27484-cit-0001" publication-type="journal">
<string-name>
<surname>Ahrens‐Nicklas</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Slap</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ficicioglu</surname>
<given-names>C</given-names>
</string-name>. <article-title>Adolescent presentations of inborn errors of metabolism</article-title>. <source xml:lang="en"/>Journal of Adolescent Health
<year>2015</year>;<volume>56</volume>:<fpage>477</fpage>‐<lpage>482</lpage>.<pub-id pub-id-type="pmid">25907648</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0002">
<label>2</label>
<mixed-citation id="mds27484-cit-0002" publication-type="journal">
<string-name>
<surname>Sanderson</surname>
<given-names>SS</given-names>
</string-name>. <article-title>The incidence of inherited metabolic disorders in the West Midlands, UK</article-title>. <source xml:lang="en"/>Arch Dis Child
<year>2006</year>;<volume>91</volume>:<fpage>896</fpage>‐<lpage>899</lpage>.<pub-id pub-id-type="pmid">16690699</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0003">
<label>3</label>
<mixed-citation id="mds27484-cit-0003" publication-type="journal">
<string-name>
<surname>Walter John</surname>
<given-names>J</given-names>
</string-name>. <article-title>IEMs in adults</article-title>. <source xml:lang="en"/>J Inherit Metab Dis
<year>2007</year>;<volume>30</volume>:<fpage>627</fpage>.<pub-id pub-id-type="pmid">17891476</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0004">
<label>4</label>
<mixed-citation id="mds27484-cit-0004" publication-type="journal">
<string-name>
<surname>Patterson</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Vecchio</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Prady</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Abel</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wraith</surname>
<given-names>JE</given-names>
</string-name>. <article-title>Miglustat for treatment of Niemann‐Pick C disease: a randomised controlled study</article-title>. <source xml:lang="en"/>Lancet Neurol
<year>2007</year>;<volume>6</volume>:<fpage>765</fpage>‐<lpage>772</lpage>.<pub-id pub-id-type="pmid">17689147</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0005">
<label>5</label>
<mixed-citation id="mds27484-cit-0005" publication-type="journal">
<string-name>
<surname>Sedel</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Saudubray</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Roze</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Agid</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Vidailhet</surname>
<given-names>M</given-names>
</string-name>. <article-title>Movement disorders and inborn errors of metabolism in adults: a diagnostic approach</article-title>. <source xml:lang="en"/>J Inherit Metab Dis
<year>2008</year>;<volume>31</volume>:<fpage>308</fpage>‐<lpage>318</lpage>.<pub-id pub-id-type="pmid">18563632</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0006">
<label>6</label>
<mixed-citation id="mds27484-cit-0006" publication-type="journal">
<string-name>
<surname>Poll‐The</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Maillette de Buy Wenniger‐Prick</surname>, <given-names>C J</given-names>
</string-name>. <article-title>The eye in metabolic diseases: clues to diagnosis</article-title>. <source xml:lang="en"/>Eur J Paediatr Neurol
<year>2011</year>;<volume>15</volume>:<fpage>197</fpage>‐<lpage>204</lpage>.<pub-id pub-id-type="pmid">21511505</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0007">
<label>7</label>
<mixed-citation id="mds27484-cit-0007" publication-type="journal">
<string-name>
<surname>Strupp</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hüfner</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Sandmann</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Zwergal</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dieterich</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jahn</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Brandt</surname>
<given-names>T</given-names>
</string-name>. <article-title>Central oculomotor disturbances and nystagmus: a window into the brainstem and cerebellum</article-title>. <source xml:lang="en"/>Dtsch Arztebl Int
<year>2011</year>;<volume>108</volume>:<fpage>197</fpage>‐<lpage>204</lpage>.<pub-id pub-id-type="pmid">21505601</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0008">
<label>8</label>
<mixed-citation id="mds27484-cit-0008" publication-type="journal">
<string-name>
<surname>Petty</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Harding</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Morgan‐Hughes</surname>
<given-names>JA</given-names>
</string-name>. <article-title>The clinical features of mitochondrial myopathy</article-title>. <source xml:lang="en"/>Brain
<year>1986</year>;<volume>109</volume>:<fpage>915</fpage>‐<lpage>938</lpage>.<pub-id pub-id-type="pmid">3779373</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0009">
<label>9</label>
<mixed-citation id="mds27484-cit-0009" publication-type="book">
<string-name>
<surname>Leigh</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Zee</surname>
<given-names>DS</given-names>
</string-name>. <source xml:lang="en"/>The Neurology of Eye Movements, <edition>5th</edition> ed. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2015</year>.</mixed-citation>
</ref>
<ref id="mds27484-bib-0010">
<label>10</label>
<mixed-citation id="mds27484-cit-0010" publication-type="journal">
<string-name>
<surname>Strupp</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kremmyda</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Adamczyk</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bottcher</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Muth</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yip</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Bremova</surname>
<given-names>T</given-names>
</string-name>. <article-title>Central ocular motor disorders, including gaze palsy and nystagmus</article-title>. <source xml:lang="en"/>J Neurol
<year>2014</year>;<volume>261</volume>(<issue>Suppl 2</issue>):<fpage>S542</fpage>‐<lpage>S545</lpage>.<pub-id pub-id-type="pmid">25145891</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0011">
<label>11</label>
<mixed-citation id="mds27484-cit-0011" publication-type="book">
<string-name>
<surname>McCaslin</surname>
<given-names>DL</given-names>
</string-name>. <source xml:lang="en"/>Electronystagmography/Videonystagmography. <publisher-loc>San Diego, CA</publisher-loc>: <publisher-name>Plural</publisher-name>; <year>2013</year>.</mixed-citation>
</ref>
<ref id="mds27484-bib-0012">
<label>12</label>
<mixed-citation id="mds27484-cit-0012" publication-type="journal">
<string-name>
<surname>Gans</surname>
<given-names>RE</given-names>
</string-name>. <article-title>Video‐oculography: a new diagnostic technology for vestibular patients</article-title>. <source xml:lang="en"/>Hearing J
<year>2001</year>;<volume>54</volume>:<fpage>40</fpage>‐<lpage>42</lpage>.</mixed-citation>
</ref>
<ref id="mds27484-bib-0013">
<label>13</label>
<mixed-citation id="mds27484-cit-0013" publication-type="journal">
<string-name>
<surname>Abel</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Walterfang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Stainer</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Bowman</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Velakoulis</surname>
<given-names>D</given-names>
</string-name>. <article-title>Longitudinal assessment of reflexive and volitional saccades in Niemann‐Pick Type C disease during treatment with miglustat</article-title>. <source xml:lang="en"/>Orphanet J Rare Dis
<year>2015</year>;<volume>10</volume>:<fpage>160</fpage>.<pub-id pub-id-type="pmid">26691656</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0014">
<label>14</label>
<mixed-citation id="mds27484-cit-0014" publication-type="journal">
<string-name>
<surname>Koens</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Kuiper</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Coenen</surname>
<given-names>MA</given-names>
</string-name>, et al. <article-title>Ataxia, dystonia and myoclonus in adult patients with Niemann‐Pick type C</article-title>. <source xml:lang="en"/>Orphanet J Rare Dis
<year>2016</year>;<volume>11</volume>:<fpage>121</fpage>.<pub-id pub-id-type="pmid">27581084</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0015">
<label>15</label>
<mixed-citation id="mds27484-cit-0015" publication-type="journal">
<string-name>
<surname>Wijburg</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Sedel</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Pineda</surname>
<given-names>M</given-names>
</string-name> et al. <article-title>Development of a suspicion index to aid diagnosis of Niemann‐Pick disease type C</article-title>. <source xml:lang="en"/>Neurology
<year>2012</year>;<volume>78</volume>:<fpage>1560</fpage>‐<lpage>1567</lpage>.<pub-id pub-id-type="pmid">22517094</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0016">
<label>16</label>
<mixed-citation id="mds27484-cit-0016" publication-type="journal">
<string-name>
<surname>Rottach</surname>
<given-names>KG</given-names>
</string-name>, <string-name>
<surname>von Maydell</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Das</surname>
<given-names>VE</given-names>
</string-name> et al. <article-title>Evidence for independent feedback control of horizontal and vertical saccades from Niemann‐Pick type C disease</article-title>. <source xml:lang="en"/>Vision Res
<year>1997</year>;<volume>37</volume>:<fpage>3627</fpage>‐<lpage>3638</lpage>.<pub-id pub-id-type="pmid">9425535</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0017">
<label>17</label>
<mixed-citation id="mds27484-cit-0017" publication-type="journal">
<string-name>
<surname>Neville</surname>
<given-names>BG</given-names>
</string-name>, <string-name>
<surname>Lake</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>Stephens</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Sanders</surname>
<given-names>MD</given-names>
</string-name>. <article-title>A neurovisceral storage disease with vertical supranuclear ophthalmoplegia, and its relationship to Niemann‐Pick disease. A report of nine patients</article-title>. <source xml:lang="en"/>Brain
<year>1973</year>;<volume>96</volume>:<fpage>97</fpage>‐<lpage>120</lpage>.<pub-id pub-id-type="pmid">4695727</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0018">
<label>18</label>
<mixed-citation id="mds27484-cit-0018" publication-type="journal">
<string-name>
<surname>Abel</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Walterfang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fietz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bowman</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Velakoulis</surname>
<given-names>D</given-names>
</string-name>. <article-title>Saccades in adult Niemann‐Pick disease type C reflect frontal, brainstem, and biochemical deficits</article-title>. <source xml:lang="en"/>Neurology
<year>2009</year>;<volume>72</volume>:<fpage>1083</fpage>‐<lpage>1086</lpage>.<pub-id pub-id-type="pmid">19307542</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0019">
<label>19</label>
<mixed-citation id="mds27484-cit-0019" publication-type="journal">
<string-name>
<surname>Eggink Hendriekje</surname>
<given-names>H</given-names>
</string-name>. <article-title>Teaching Video NeuroImages: The “round the houses” sign as a clinical clue for Niemann‐Pick disease type C</article-title>. <source xml:lang="en"/>Neurology
<year>2016</year>;<volume>86</volume>:<fpage>e202</fpage>.<pub-id pub-id-type="pmid">27164722</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0020">
<label>20</label>
<mixed-citation id="mds27484-cit-0020" publication-type="journal">
<string-name>
<surname>Bremova</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Krafczyk</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bardins</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Reinke</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Strupp</surname>
<given-names>M</given-names>
</string-name>. <article-title>Vestibular function in patients with Niemann‐Pick type C disease</article-title>. <source xml:lang="en"/>J Neurol
<year>2016</year>;<volume>263</volume>:<fpage>2260</fpage>‐<lpage>2270</lpage>.<pub-id pub-id-type="pmid">27544496</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0021">
<label>21</label>
<mixed-citation id="mds27484-cit-0021" publication-type="book">
<string-name>
<surname>Hollak</surname>
<given-names>CEM</given-names>
</string-name>, <string-name>
<surname>Lachman</surname>
<given-names>R</given-names>
</string-name>. <source xml:lang="en"/>Inherited Metabolic Disease in Adults: A Clinical Guide. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2016</year>.</mixed-citation>
</ref>
<ref id="mds27484-bib-0022">
<label>22</label>
<mixed-citation id="mds27484-cit-0022" publication-type="journal">
<string-name>
<surname>Accardo</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Pensiero</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Perissutti</surname>
<given-names>P</given-names>
</string-name>. <article-title>Saccadic analysis for early identification of neurological involvement in Gaucher disease</article-title>. <source xml:lang="en"/>Ann N Y Acad Sci
<year>2005</year>;<volume>1039</volume>:<fpage>503</fpage>‐<lpage>507</lpage>.<pub-id pub-id-type="pmid">15827009</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0023">
<label>23</label>
<mixed-citation id="mds27484-cit-0023" publication-type="journal">
<string-name>
<surname>Mignot</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Doummar</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Maire</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>De Villemeur</surname>
<given-names>TB</given-names>
</string-name>. <article-title>Type 2 Gaucher disease: 15 new cases and review of the literature</article-title>. <source xml:lang="en"/>Brain Dev
<year>2006</year>;<volume>28</volume>:<fpage>39</fpage>‐<lpage>48</lpage>.<pub-id pub-id-type="pmid">16485335</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0024">
<label>24</label>
<mixed-citation id="mds27484-cit-0024" publication-type="journal">
<string-name>
<surname>Tylki‐Szymanska</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Vellodi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>El‐Beshlawy</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cole</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Kolodny</surname>
<given-names>E</given-names>
</string-name>. <article-title>Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry</article-title>. <source xml:lang="en"/>J Inherit Metab Dis
<year>2010</year>;<volume>33</volume>:<fpage>339</fpage>‐<lpage>346</lpage>.<pub-id pub-id-type="pmid">20084461</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0025">
<label>25</label>
<mixed-citation id="mds27484-cit-0025" publication-type="journal">
<string-name>
<surname>Cogan</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>FC</given-names>
</string-name>, <string-name>
<surname>Reingold</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Barranger</surname>
<given-names>J</given-names>
</string-name>. <article-title>Ocular motor signs in some metabolic diseases</article-title>. <source xml:lang="en"/>Arch Ophthalmol
<year>1981</year>;<volume>99</volume>:<fpage>1802</fpage>‐<lpage>1808</lpage>.<pub-id pub-id-type="pmid">7295130</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0026">
<label>26</label>
<mixed-citation id="mds27484-cit-0026" publication-type="journal">
<string-name>
<surname>Accardo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pensiero</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ciana</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Parentin</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bembi</surname>
<given-names>B</given-names>
</string-name>. <article-title>Eye movement impairment recovery in a Gaucher patient treated with miglustat</article-title>. <source xml:lang="en"/>Neurol Res Int
<year>2010</year>;<volume>2010</volume>:<fpage>358534</fpage>.<pub-id pub-id-type="pmid">21152212</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0027">
<label>27</label>
<mixed-citation id="mds27484-cit-0027" publication-type="journal">
<string-name>
<surname>Park</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Orvisky</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tayebi</surname>
<given-names>N</given-names>
</string-name> et al. <article-title>Myoclonic epilepsy in Gaucher disease: genotype‐phenotype insights from a rare patient subgroup</article-title>. <source xml:lang="en"/>Pediatr Res
<year>2003</year>;<volume>53</volume>:<fpage>387</fpage>‐<lpage>395</lpage>.<pub-id pub-id-type="pmid">12595585</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0028">
<label>28</label>
<mixed-citation id="mds27484-cit-0028" publication-type="journal">
<string-name>
<surname>Sharma</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lal</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Das</surname>
<given-names>R</given-names>
</string-name>. <article-title>Horizontal gaze palsy with progressive myoclonic epilepsy: rare presentation of Gaucher's disease</article-title>. <source xml:lang="en"/>Neurol India
<year>2013</year>;<volume>61</volume>:<fpage>177</fpage>‐<lpage>178</lpage>.<pub-id pub-id-type="pmid">23644323</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0029">
<label>29</label>
<mixed-citation id="mds27484-cit-0029" publication-type="journal">
<string-name>
<surname>Benko</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Ries</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wiggs</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Brady</surname>
<given-names>RO</given-names>
</string-name>, <string-name>
<surname>Schiffmann</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Fitzgibbon</surname>
<given-names>EJ</given-names>
</string-name>. <article-title>The saccadic and neurological deficits in type 3 Gaucher disease</article-title>. <source xml:lang="en"/>PLoS One
<year>2011</year>;<volume>6</volume>:<fpage>e22410</fpage>.<pub-id pub-id-type="pmid">21799847</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0030">
<label>30</label>
<mixed-citation id="mds27484-cit-0030" publication-type="journal">
<string-name>
<surname>Accardo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bembi</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Pensiero</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Perissutti</surname>
<given-names>P</given-names>
</string-name>. <article-title>Type 3 Gaucher's disease in a three‐year‐old child: saccadic eye movements analysis</article-title>. <source xml:lang="en"/>J AAPOS
<year>2005</year>;<volume>9</volume>:<fpage>501</fpage>‐<lpage>503</lpage>.<pub-id pub-id-type="pmid">16213406</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0031">
<label>31</label>
<mixed-citation id="mds27484-cit-0031" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Halmagyi</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Todd</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Aw</surname>
<given-names>ST</given-names>
</string-name>. <article-title>Vestibular and Saccadic Abnormalities in Gaucher's Disease</article-title>. <source xml:lang="en"/>JIMD Rep
<year>2014</year>;<volume>13</volume>:<fpage>111</fpage>‐<lpage>118</lpage>.<pub-id pub-id-type="pmid">24142279</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0032">
<label>32</label>
<mixed-citation id="mds27484-cit-0032" publication-type="journal">
<string-name>
<surname>Gross‐Tsur</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Har‐Even</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gutman</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Amir</surname>
<given-names>N</given-names>
</string-name>. <article-title>Oculomotor apraxia: the presenting sign of Gaucher disease</article-title>. <source xml:lang="en"/>Pediatr Neurol
<year>1989</year>;<volume>5</volume>:<fpage>128</fpage>‐<lpage>129</lpage>.<pub-id pub-id-type="pmid">2712947</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0033">
<label>33</label>
<mixed-citation id="mds27484-cit-0033" publication-type="journal">
<string-name>
<surname>Blume</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Beniaminov</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kämpe Björkvall</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Machaczka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Svenningsson</surname>
<given-names>P</given-names>
</string-name>. <article-title>Saccadic impairments in patients with the norrbottnian form of Gaucher's disease type 3</article-title>. <source xml:lang="en"/>Front Neurol
<year>2017</year>;<volume>8</volume>:<fpage>295</fpage>.<pub-id pub-id-type="pmid">28690585</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0034">
<label>34</label>
<mixed-citation id="mds27484-cit-0034" publication-type="journal">
<string-name>
<surname>Pastores</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Barnett</surname>
<given-names>NL</given-names>
</string-name>, <string-name>
<surname>Bathan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kolodny</surname>
<given-names>EH</given-names>
</string-name>. <article-title>A neurological symptom survey of patients with type I Gaucher disease</article-title>. <source xml:lang="en"/>J Inherit Metab Dis
<year>2003</year>;<volume>26</volume>:<fpage>641</fpage>‐<lpage>645</lpage>.<pub-id pub-id-type="pmid">14707512</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0035">
<label>35</label>
<mixed-citation id="mds27484-cit-0035" publication-type="journal">
<string-name>
<surname>Capablo</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Saenz de Cabezon</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fraile</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Alfonso</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Pocovi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Giraldo</surname>
<given-names>P</given-names>
</string-name>, <collab collab-type="authors">Spanish Group on Gaucher Disease</collab>
. <article-title>Neurological evaluation of patients with Gaucher disease diagnosed as type 1</article-title>. <source xml:lang="en"/>J Neurol Neurosurg Psychiatry
<year>2008</year>;<volume>79</volume>:<fpage>219</fpage>‐<lpage>222</lpage>.<pub-id pub-id-type="pmid">17682016</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0036">
<label>36</label>
<mixed-citation id="mds27484-cit-0036" publication-type="journal">
<string-name>
<surname>Sidransky</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tsuji</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Stubblefield</surname>
<given-names>BK</given-names>
</string-name>, <string-name>
<surname>Currie</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>FitzGibbon</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Ginns</surname>
<given-names>EI</given-names>
</string-name>. <article-title>Gaucher patients with oculomotor abnormalities do not have a unique genotype</article-title>. <source xml:lang="en"/>Clin Genet
<year>1992</year>;<volume>41</volume>:<fpage>1</fpage>‐<lpage>5</lpage>.<pub-id pub-id-type="pmid">1633639</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0037">
<label>37</label>
<mixed-citation id="mds27484-cit-0037" publication-type="journal">
<string-name>
<surname>Rucker</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Shapiro</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Garbutt</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Keller</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Leigh</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Neuro‐ophthalmology of late‐onset Tay‐Sachs disease (LOTS)</article-title>. <source xml:lang="en"/>Neurology
<year>2004</year>;<volume>63</volume>:<fpage>1918</fpage>‐<lpage>1926</lpage>.<pub-id pub-id-type="pmid">15557512</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0038">
<label>38</label>
<mixed-citation id="mds27484-cit-0038" publication-type="journal">
<string-name>
<surname>Optican</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Rucker</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Keller</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Leigh</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Mechanism of interrupted saccades in patients with late‐onset Tay‐Sachs disease</article-title>. <source xml:lang="en"/>Prog Brain Res
<year>2008</year>;<volume>171</volume>:<fpage>567</fpage>‐<lpage>570</lpage>.<pub-id pub-id-type="pmid">18718355</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0039">
<label>39</label>
<mixed-citation id="mds27484-cit-0039" publication-type="journal">
<string-name>
<surname>Barnes</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Misra</surname>
<given-names>VP</given-names>
</string-name>, <string-name>
<surname>Young</surname>
<given-names>EP</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Harding</surname>
<given-names>AE</given-names>
</string-name>. <article-title>An adult onset hexosaminidase A deficiency syndrome with sensory neuropathy and internuclear ophthalmoplegia</article-title>. <source xml:lang="en"/>J Neurol Neurosurg Psychiatry
<year>1991</year>;<volume>54</volume>:<fpage>1112</fpage>‐<lpage>1113</lpage>.<pub-id pub-id-type="pmid">1838393</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0040">
<label>40</label>
<mixed-citation id="mds27484-cit-0040" publication-type="journal">
<string-name>
<surname>Hund</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Grau</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fogel</surname>
<given-names>W</given-names>
</string-name> et al. <article-title>Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexosaminidase A deficiency with late clinical onset in four siblings</article-title>. <source xml:lang="en"/>J Neurol Sci
<year>1997</year>;<volume>145</volume>:<fpage>25</fpage>‐<lpage>31</lpage>.<pub-id pub-id-type="pmid">9073025</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0041">
<label>41</label>
<mixed-citation id="mds27484-cit-0041" publication-type="journal">
<string-name>
<surname>Pretegiani</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Rosini</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Federighi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Cerase</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dotti</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Rufa</surname>
<given-names>A</given-names>
</string-name>. <article-title>Pendular nystagmus, palatal tremor and progressive ataxia in GM2‐gangliosidosis</article-title>. <source xml:lang="en"/>Eur J Neurol
<year>2015</year>;<volume>22</volume>:<fpage>e67</fpage>‐<lpage>e69</lpage>.<pub-id pub-id-type="pmid">25916337</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0042">
<label>42</label>
<mixed-citation id="mds27484-cit-0042" publication-type="journal">
<string-name>
<surname>Masri</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kornreich</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Haghighi</surname>
<given-names>A</given-names>
</string-name>. <article-title>Homozygous p.R284* mutation in HEXB gene causing Sandhoff disease with nystagmus</article-title>. <source xml:lang="en"/>Eur J Paediatr Neurol
<year>2014</year>;<volume>18</volume>:<fpage>399</fpage>‐<lpage>403</lpage>.<pub-id pub-id-type="pmid">24613245</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0043">
<label>43</label>
<mixed-citation id="mds27484-cit-0043" publication-type="journal">
<string-name>
<surname>Yun</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>SN</given-names>
</string-name>. <article-title>A case refort of Sandhoff disease</article-title>. <source xml:lang="en"/>Korean J Ophthalmol
<year>2005</year>;<volume>19</volume>:<fpage>68</fpage>‐<lpage>72</lpage>.<pub-id pub-id-type="pmid">15929490</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0044">
<label>44</label>
<mixed-citation id="mds27484-cit-0044" publication-type="journal">
<string-name>
<surname>Yee</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Cogan</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Zee</surname>
<given-names>DS</given-names>
</string-name>. <article-title>Ophthalmoplegia and dissociated nystagmus in adetalipoproteinemia</article-title>. <source xml:lang="en"/>Arch Ophthalmol
<year>1976</year>;<volume>94</volume>:<fpage>571</fpage>‐<lpage>575</lpage>.<pub-id pub-id-type="pmid">1267635</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0045">
<label>45</label>
<mixed-citation id="mds27484-cit-0045" publication-type="book">
<string-name>
<surname>Federico</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dotti</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Gallus</surname>
<given-names>GN</given-names>
</string-name>. <chapter-title>Cerebrotendinous Xanthomatosis</chapter-title> In: <person-group person-group-type="editor"><name><surname>Pagon</surname><given-names>RA</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Adam</surname><given-names>MP</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Ardinger</surname><given-names>HH</given-names></name></person-group> et al. <source xml:lang="en"/>GeneReviews(®). <publisher-loc>Seattle (WA)</publisher-loc>: <publisher-name>University of Washington, Seattle</publisher-name>
<fpage>1993</fpage>‐<lpage>2017</lpage>.</mixed-citation>
</ref>
<ref id="mds27484-bib-0046">
<label>46</label>
<mixed-citation id="mds27484-cit-0046" publication-type="journal">
<string-name>
<surname>Rosini</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Pretegiani</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mignarri</surname>
<given-names>A</given-names>
</string-name> et al. <article-title>The role of dentate nuclei in human oculomotor control: insights from cerebrotendinous xanthomatosis</article-title>. <source xml:lang="en"/>J Physiol (Lond )
<year>2017</year>;<volume>595</volume>:<fpage>3607</fpage>‐<lpage>3620</lpage>.<pub-id pub-id-type="pmid">28168705</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0047">
<label>47</label>
<mixed-citation id="mds27484-cit-0047" publication-type="journal">
<string-name>
<surname>Berginer</surname>
<given-names>VM</given-names>
</string-name>, <string-name>
<surname>Gross</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Morad</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kfir</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Morkos</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aaref</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Falik‐Zaccai</surname>
<given-names>TC</given-names>
</string-name>. <article-title>Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat</article-title>. <source xml:lang="en"/>Pediatrics
<year>2009</year>;<volume>123</volume>:<fpage>143</fpage>‐<lpage>147</lpage>.<pub-id pub-id-type="pmid">19117873</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0048">
<label>48</label>
<mixed-citation id="mds27484-cit-0048" publication-type="journal">
<string-name>
<surname>Van Heijst</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Verrips</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wevers</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Cruysberg</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Renier</surname>
<given-names>WO</given-names>
</string-name>, <string-name>
<surname>Tolboom</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>Treatment and follow‐up of children with cerebrotendinous xanthomatosis</article-title>. <source xml:lang="en"/>Eur J Pediatr
<year>1998</year>;<volume>157</volume>:<fpage>313</fpage>‐<lpage>316</lpage>.<pub-id pub-id-type="pmid">9578968</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0049">
<label>49</label>
<mixed-citation id="mds27484-cit-0049" publication-type="journal">
<string-name>
<surname>De Giorgis</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Varesio</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Baldassari</surname>
<given-names>C</given-names>
</string-name> et al. <article-title>Atypical manifestations in Glut1 deficiency syndrome</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2016</year>;<volume>31</volume>:<fpage>1174</fpage>‐<lpage>1180</lpage>.<pub-id pub-id-type="pmid">27250207</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0050">
<label>50</label>
<mixed-citation id="mds27484-cit-0050" publication-type="journal">
<string-name>
<surname>Pearson</surname>
<given-names>TS</given-names>
</string-name>, <string-name>
<surname>Pons</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Engelstad</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kane</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Goldberg</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>De Vivo</surname>
<given-names>DC</given-names>
</string-name>. <article-title>Paroxysmal eye‐head movements in Glut1 deficiency syndrome</article-title>. <source xml:lang="en"/>Neurology
<year>2017</year>; <volume>88</volume>:<fpage>1666</fpage>‐<lpage>1673</lpage>.<pub-id pub-id-type="pmid">28341645</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0051">
<label>51</label>
<mixed-citation id="mds27484-cit-0051" publication-type="journal">
<string-name>
<surname>Akman</surname>
<given-names>CI</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Alter</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Engelstad</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>De Vivo</surname>
<given-names>DC</given-names>
</string-name>. <article-title>Diagnosing glucose transporter 1 deficiency at initial presentation facilitates early treatment</article-title>. <source xml:lang="en"/>J Pediatr
<year>2016</year>;<volume>171</volume>:<fpage>220</fpage>‐<lpage>226</lpage>.<pub-id pub-id-type="pmid">26811264</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0052">
<label>52</label>
<mixed-citation id="mds27484-cit-0052" publication-type="journal">
<string-name>
<surname>Ito</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kagitani‐Shimono</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Natsume</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yanagihara</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fujii</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Oguni</surname>
<given-names>H</given-names>
</string-name>. <article-title>Nationwide survey of glucose transporter‐1 deficiency syndrome (GLUT‐1DS) in Japan</article-title>. <source xml:lang="en"/>Brain Dev
<year>2015</year>;<volume>37</volume>:<fpage>780</fpage>‐<lpage>789</lpage>.<pub-id pub-id-type="pmid">25487684</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0053">
<label>53</label>
<mixed-citation id="mds27484-cit-0053" publication-type="journal">
<string-name>
<surname>Hyman</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Phuapradit</surname>
<given-names>P</given-names>
</string-name>. <article-title>Reading difficulty as a presenting symptom in Wilson's disease</article-title>. <source xml:lang="en"/>J Neurol Neurosurg Psychiatry
<year>1979</year>;<volume>42</volume>:<fpage>478</fpage>‐<lpage>480</lpage>.<pub-id pub-id-type="pmid">448388</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0054">
<label>54</label>
<mixed-citation id="mds27484-cit-0054" publication-type="journal">
<string-name>
<surname>Jung</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>J</given-names>
</string-name>. <article-title>Selective slowing of downward saccades in Wilson's disease</article-title>. <source xml:lang="en"/>Parkinsonism Relat Disord
<year>2013</year>;<volume>19</volume>:<fpage>134</fpage>‐<lpage>135</lpage>.<pub-id pub-id-type="pmid">22721972</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0055">
<label>55</label>
<mixed-citation id="mds27484-cit-0055" publication-type="journal">
<string-name>
<surname>Ingster‐Moati</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bui Quoc</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Pless</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Djomby</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Orssaud</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Guichard</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Woimant</surname>
<given-names>F</given-names>
</string-name>. <article-title>Ocular motility and Wilson's disease: a study on 34 patients</article-title>. <source xml:lang="en"/>J Neurol Neurosurg Psychiatry
<year>2007</year>;<volume>78</volume>:<fpage>1199</fpage>‐<lpage>1201</lpage>.<pub-id pub-id-type="pmid">17470473</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0056">
<label>56</label>
<mixed-citation id="mds27484-cit-0056" publication-type="journal">
<string-name>
<surname>Lesniak</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Czlonkowska</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Seniow</surname>
<given-names>J</given-names>
</string-name>. <article-title>Abnormal antisaccades and smooth pursuit eye movements in patients with Wilson's disease</article-title>. <source xml:lang="en"/>Mov Disord
<year>2008</year>;<volume>23</volume>:<fpage>2067</fpage>‐<lpage>2073</lpage>.<pub-id pub-id-type="pmid">18759342</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0057">
<label>57</label>
<mixed-citation id="mds27484-cit-0057" publication-type="journal">
<string-name>
<surname>Kirkham</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Kamin</surname>
<given-names>DF</given-names>
</string-name>. <article-title>Slow saccadic eye movements in Wilson's disease</article-title>. <source xml:lang="en"/>J Neurol Neurosurg Psychiatry
<year>1974</year>;<volume>37</volume>:<fpage>191</fpage>‐<lpage>194</lpage>.<pub-id pub-id-type="pmid">4819908</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0058">
<label>58</label>
<mixed-citation id="mds27484-cit-0058" publication-type="journal">
<string-name>
<surname>Lennox</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>R</given-names>
</string-name>. <article-title>Gaze distractibility in Wilson's disease</article-title>. <source xml:lang="en"/>Ann Neurol
<year>1989</year>;<volume>25</volume>:<fpage>415</fpage>‐<lpage>417</lpage>.<pub-id pub-id-type="pmid">2712535</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0059">
<label>59</label>
<mixed-citation id="mds27484-cit-0059" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>YD</given-names>
</string-name>, <string-name>
<surname>Lyoo</surname>
<given-names>CH</given-names>
</string-name>. <article-title>Oculogyric crisis as an initial manifestation of Wilson's disease</article-title>. <source xml:lang="en"/>Neurology
<year>1999</year>;<volume>52</volume>:<fpage>1714</fpage>‐<lpage>1715</lpage>.<pub-id pub-id-type="pmid">10331711</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0060">
<label>60</label>
<mixed-citation id="mds27484-cit-0060" publication-type="journal">
<string-name>
<surname>Zupanc</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Chun</surname>
<given-names>RW</given-names>
</string-name>, <string-name>
<surname>Gilbert‐Barness</surname>
<given-names>EF</given-names>
</string-name>. <article-title>Osmiophilic deposits in cytosomes in Hallervorden‐Spatz syndrome</article-title>. <source xml:lang="en"/>Pediatr Neurol
<year>1990</year>;<volume>6</volume>:<fpage>349</fpage>‐<lpage>352</lpage>.<pub-id pub-id-type="pmid">1700720</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0061">
<label>61</label>
<mixed-citation id="mds27484-cit-0061" publication-type="journal">
<string-name>
<surname>Hayflick</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Westaway</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Levinson</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Ching</surname>
<given-names>KHL</given-names>
</string-name>, <string-name>
<surname>Gitschier</surname>
<given-names>J</given-names>
</string-name>. <article-title>Genetic, clinical, and radiographic delineation of Hallervorden‐Spatz syndrome</article-title>. <source xml:lang="en"/>N Engl J Med
<year>2003</year>;<volume>348</volume>:<fpage>33</fpage>‐<lpage>40</lpage>.<pub-id pub-id-type="pmid">12510040</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0062">
<label>62</label>
<mixed-citation id="mds27484-cit-0062" publication-type="journal">
<string-name>
<surname>Egan</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Weleber</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Hogarth</surname>
<given-names>P</given-names>
</string-name> et al. <article-title>Neuro‐ophthalmologic and electroretinographic findings in pantothenate kinase‐associated neurodegeneration (formerly Hallervorden‐Spatz syndrome)</article-title>. <source xml:lang="en"/>Am J Ophthalmol
<year>2005</year>;<volume>140</volume>:<fpage>267</fpage>‐<lpage>274</lpage>.<pub-id pub-id-type="pmid">16023068</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0063">
<label>63</label>
<mixed-citation id="mds27484-cit-0063" publication-type="journal">
<string-name>
<surname>Bozi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Matarin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Theocharis</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Potagas</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Stefanis</surname>
<given-names>L</given-names>
</string-name>. <article-title>A patient with pantothenate kinase‐associated neurodegeneration and supranuclear gaze palsy</article-title>. <source xml:lang="en"/>Clin Neurol Neurosurg
<year>2009</year>;<volume>111</volume>:<fpage>688</fpage>‐<lpage>690</lpage>.<pub-id pub-id-type="pmid">19570605</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0064">
<label>64</label>
<mixed-citation id="mds27484-cit-0064" publication-type="journal">
<string-name>
<surname>Khan</surname>
<given-names>AO</given-names>
</string-name>, <string-name>
<surname>AlDrees</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Elmalik</surname>
<given-names>SA</given-names>
</string-name> et al. <article-title>Ophthalmic features of PLA2G6‐related paediatric neurodegeneration with brain iron accumulation</article-title>. <source xml:lang="en"/>Br J Ophthalmol
<year>2014</year>;<volume>98</volume>:<fpage>889</fpage>‐<lpage>893</lpage>.<pub-id pub-id-type="pmid">24522175</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0065">
<label>65</label>
<mixed-citation id="mds27484-cit-0065" publication-type="journal">
<string-name>
<surname>Virmani</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Thenganatt</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Goldman</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Kubisch</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Greene</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Alcalay</surname>
<given-names>RN</given-names>
</string-name>. <article-title>Oculogyric crises induced by levodopa in PLA2G6 parkinsonism‐dystonia</article-title>. <source xml:lang="en"/>Parkinsonism Relat Disord
<year>2014</year>;<volume>20</volume>:<fpage>245</fpage>‐<lpage>247</lpage>.<pub-id pub-id-type="pmid">24182522</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0066">
<label>66</label>
<mixed-citation id="mds27484-cit-0066" publication-type="journal">
<string-name>
<surname>Alfadhel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Almuntashri</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jadah</surname>
<given-names>RH</given-names>
</string-name> et al. <article-title>Biotin‐responsive basal ganglia disease should be renamed biotin‐thiamine‐responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases</article-title>. <source xml:lang="en"/>Orphanet J Rare Dis
<year>2013</year>;<volume>8</volume>:<fpage>83</fpage>.<pub-id pub-id-type="pmid">23742248</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0067">
<label>67</label>
<mixed-citation id="mds27484-cit-0067" publication-type="journal">
<string-name>
<surname>Fassone</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Wedatilake</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>DeVile</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Chong</surname>
<given-names>WK</given-names>
</string-name>, <string-name>
<surname>Carr</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Rahman</surname>
<given-names>S</given-names>
</string-name>. <article-title>Treatable Leigh‐like encephalopathy presenting in adolescence</article-title>. <source xml:lang="en"/>BMJ Case Rep
<year>2013</year>;<volume>2013</volume>:<fpage>200838</fpage>.</mixed-citation>
</ref>
<ref id="mds27484-bib-0068">
<label>68</label>
<mixed-citation id="mds27484-cit-0068" publication-type="journal">
<string-name>
<surname>Tabarki</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Al‐Sheikh</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Al‐Shahwan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zuccoli</surname>
<given-names>G</given-names>
</string-name>. <article-title>Bilateral external ophthalmoplegia in biotin‐responsive basal ganglia disease</article-title>. <source xml:lang="en"/>J Pediatr
<year>2013</year>;<volume>162</volume>:<fpage>1291</fpage>‐<lpage>1292</lpage>.<pub-id pub-id-type="pmid">23360564</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0069">
<label>69</label>
<mixed-citation id="mds27484-cit-0069" publication-type="journal">
<string-name>
<surname>Ozand</surname>
<given-names>PT</given-names>
</string-name>, <string-name>
<surname>Gascon</surname>
<given-names>GG</given-names>
</string-name>, <string-name>
<surname>Al Essa</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Biotin‐responsive basal ganglia disease: a novel entity</article-title>. <source xml:lang="en"/>Brain
<year>1998</year>;<volume>121</volume>:<fpage>1267</fpage>‐<lpage>1279</lpage>.<pub-id pub-id-type="pmid">9679779</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0070">
<label>70</label>
<mixed-citation id="mds27484-cit-0070" publication-type="journal">
<string-name>
<surname>El Euch‐Fayache</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bouhlal</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Amouri</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Feki</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hentati</surname>
<given-names>F</given-names>
</string-name>. <article-title>Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency</article-title>. <source xml:lang="en"/>Brain
<year>2014</year>;<volume>137</volume>:<fpage>402</fpage>‐<lpage>410</lpage>.<pub-id pub-id-type="pmid">24369383</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0071">
<label>71</label>
<mixed-citation id="mds27484-cit-0071" publication-type="journal">
<string-name>
<surname>Tamaru</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hirano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kusaka</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Imai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ueno</surname>
<given-names>S</given-names>
</string-name>. <article-title>alpha‐Tocopherol transfer protein gene: exon skipping of all transcripts causes ataxia</article-title>. <source xml:lang="en"/>Neurology
<year>1997</year>;<volume>49</volume>:<fpage>584</fpage>‐<lpage>588</lpage>.<pub-id pub-id-type="pmid">9270601</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0072">
<label>72</label>
<mixed-citation id="mds27484-cit-0072" publication-type="journal">
<string-name>
<surname>Gabsi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gouider‐Khouja</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Belal</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency</article-title>. <source xml:lang="en"/>Eur J Neurol
<year>2001</year>;<volume>8</volume>:<fpage>477</fpage>‐<lpage>481</lpage>.<pub-id pub-id-type="pmid">11554913</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0073">
<label>73</label>
<mixed-citation id="mds27484-cit-0073" publication-type="journal">
<string-name>
<surname>Zee</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Freeman</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Holtzman</surname>
<given-names>NA</given-names>
</string-name>. <article-title>Ophthalmoplegia in maple syrup urine disease</article-title>. <source xml:lang="en"/>J Pediatr
<year>1974</year>;<volume>84</volume>:<fpage>113</fpage>‐<lpage>115</lpage>.<pub-id pub-id-type="pmid">12119930</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0074">
<label>74</label>
<mixed-citation id="mds27484-cit-0074" publication-type="journal">
<string-name>
<surname>Gupta</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Waggoner</surname>
<given-names>D</given-names>
</string-name>. <article-title>Ophthalmoplegia in maple syrup urine disease</article-title>. <source xml:lang="en"/>J AAPOS
<year>2003</year>;<volume>7</volume>:<fpage>300</fpage>‐<lpage>302</lpage>.<pub-id pub-id-type="pmid">12917622</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0075">
<label>75</label>
<mixed-citation id="mds27484-cit-0075" publication-type="journal">
<string-name>
<surname>Chhabria</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tomasi</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>PW</given-names>
</string-name>. <article-title>Ophthalmoplegia and bulbar palsy in variant form of maple syrup urine disease</article-title>. <source xml:lang="en"/>Ann Neurol
<year>1979</year>;<volume>6</volume>:<fpage>71</fpage>‐<lpage>72</lpage>.<pub-id pub-id-type="pmid">507761</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0076">
<label>76</label>
<mixed-citation id="mds27484-cit-0076" publication-type="journal">
<string-name>
<surname>Kafil‐Hussain</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Monavari</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bowell</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Thornton</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Naughten</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>O'Keefe</surname>
<given-names>M</given-names>
</string-name>. <article-title>Ocular findings in glutaric aciduria type 1</article-title>. <source xml:lang="en"/>J Pediatr Ophthalmol Strabismus
<year>2000</year>;<volume>37</volume>:<fpage>289</fpage>‐<lpage>293</lpage>.<pub-id pub-id-type="pmid">11020111</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0077">
<label>77</label>
<mixed-citation id="mds27484-cit-0077" publication-type="journal">
<string-name>
<surname>Bahr</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Mader</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Zschocke</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dichgans</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schulz</surname>
<given-names>JB</given-names>
</string-name>. <article-title>Adult onset glutaric aciduria type I presenting with a leukoencephalopathy</article-title>. <source xml:lang="en"/>Neurology
<year>2002</year>;<volume>59</volume>:<fpage>1802</fpage>‐<lpage>1804</lpage>.<pub-id pub-id-type="pmid">12473778</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0078">
<label>78</label>
<mixed-citation id="mds27484-cit-0078" publication-type="journal">
<string-name>
<surname>Vermeer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kremer</surname>
<given-names>HPH</given-names>
</string-name>, <string-name>
<surname>Leijten</surname>
<given-names>QH</given-names>
</string-name>, et al. <article-title>Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG‐Ia) with normal routine CDG screening</article-title>. <source xml:lang="en"/>J Neurol
<year>2007</year>;<volume>254</volume>:<fpage>1356</fpage>‐<lpage>1358</lpage>.<pub-id pub-id-type="pmid">17694350</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0079">
<label>79</label>
<mixed-citation id="mds27484-cit-0079" publication-type="journal">
<string-name>
<surname>Messenger</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Pennesi</surname>
<given-names>ME</given-names>
</string-name>. <article-title>Ophthalmic findings in an infant with phosphomannomutase deficiency</article-title>. <source xml:lang="en"/>Doc Ophthalmol
<year>2014</year>;<volume>128</volume>:<fpage>149</fpage>‐<lpage>153</lpage>.<pub-id pub-id-type="pmid">24493206</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0080">
<label>80</label>
<mixed-citation id="mds27484-cit-0080" publication-type="journal">
<string-name>
<surname>Coorg</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lotze</surname>
<given-names>TE</given-names>
</string-name>. <article-title>Child Neurology: a case of PMM2‐CDG (CDG 1a) presenting with unusual eye movements</article-title>. <source xml:lang="en"/>Neurology
<year>2012</year>;<volume>79</volume>:<fpage>e131</fpage>‐<lpage>e133</lpage>.<pub-id pub-id-type="pmid">23045520</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0081">
<label>81</label>
<mixed-citation id="mds27484-cit-0081" publication-type="journal">
<string-name>
<surname>Stark</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Gibson</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Hertle</surname>
<given-names>RW</given-names>
</string-name>, <string-name>
<surname>Brodsky</surname>
<given-names>MC</given-names>
</string-name>. <article-title>Ocular motor signs in an infant with carbohydrate‐deficient glycoprotein syndrome type Ia</article-title>. <source xml:lang="en"/>Am J Ophthalmol
<year>2000</year>;<volume>130</volume>:<fpage>533</fpage>‐<lpage>535</lpage>.<pub-id pub-id-type="pmid">11024435</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0082">
<label>82</label>
<mixed-citation id="mds27484-cit-0082" publication-type="journal">
<string-name>
<surname>Morava</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Wosik</surname>
<given-names>HN</given-names>
</string-name>, <string-name>
<surname>Sykut‐Cegielska</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Ophthalmological abnormalities in children with congenital disorders of glycosylation type I</article-title>. <source xml:lang="en"/>Br J Ophthalmol
<year>2009</year>;<volume>93</volume>:<fpage>350</fpage>‐<lpage>354</lpage>.<pub-id pub-id-type="pmid">19019927</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0083">
<label>83</label>
<mixed-citation id="mds27484-cit-0083" publication-type="journal">
<string-name>
<surname>Jinnah</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Lewis</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Visser</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Eddey</surname>
<given-names>GE</given-names>
</string-name>, <string-name>
<surname>Barabas</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Harris</surname>
<given-names>JC</given-names>
</string-name>. <article-title>Ocular motor dysfunction in Lesch‐Nyhan disease</article-title>. <source xml:lang="en"/>Pediatr Neurol
<year>2001</year>;<volume>24</volume>:<fpage>200</fpage>‐<lpage>204</lpage>.<pub-id pub-id-type="pmid">11301220</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0084">
<label>84</label>
<mixed-citation id="mds27484-cit-0084" publication-type="journal">
<string-name>
<surname>Poll‐The</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Gootjes</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Duran</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Peroxisome biogenesis disorders with prolonged survival: phenotypic expression in a cohort of 31 patients</article-title>. <source xml:lang="en"/>Am J Med Genet A
<year>2004</year>;<volume>126A</volume>:<fpage>333</fpage>‐<lpage>338</lpage>.<pub-id pub-id-type="pmid">15098231</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0085">
<label>85</label>
<mixed-citation id="mds27484-cit-0085" publication-type="journal">
<string-name>
<surname>Rosini</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Vinciguerra</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mignarri</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Di Giovanni</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Federico</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rufa</surname>
<given-names>A</given-names>
</string-name>. <article-title>Eye movement abnormalities in a patient with Zellweger spectrum disorder</article-title>. <source xml:lang="en"/>Neurol Sci
<year>2016</year>;<volume>37</volume>:<fpage>1013</fpage>‐<lpage>1015</lpage>.<pub-id pub-id-type="pmid">26850714</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0086">
<label>86</label>
<mixed-citation id="mds27484-cit-0086" publication-type="journal">
<string-name>
<surname>Kori</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Robin</surname>
<given-names>NH</given-names>
</string-name>, <string-name>
<surname>Jacobs</surname>
<given-names>JB</given-names>
</string-name>, et al. <article-title>Pendular nystagmus in patients with peroxisomal assembly disorder</article-title>. <source xml:lang="en"/>Arch Neurol
<year>1998</year>;<volume>55</volume>:<fpage>554</fpage>‐<lpage>558</lpage>.<pub-id pub-id-type="pmid">9561985</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0087">
<label>87</label>
<mixed-citation id="mds27484-cit-0087" publication-type="journal">
<string-name>
<surname>Kurian</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhen</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study</article-title>. <source xml:lang="en"/>Lancet Neurol
<year>2011</year>;<volume>10</volume>:<fpage>54</fpage>‐<lpage>62</lpage>.<pub-id pub-id-type="pmid">21112253</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0088">
<label>88</label>
<mixed-citation id="mds27484-cit-0088" publication-type="journal">
<string-name>
<surname>Wijemanne</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jankovic</surname>
<given-names>J</given-names>
</string-name>. <article-title>Dopa‐responsive dystonia‐clinical and genetic heterogeneity</article-title>. <source xml:lang="en"/>Nat Rev Neurol
<year>2015</year>;<volume>11</volume>:<fpage>414</fpage>‐<lpage>424</lpage>.<pub-id pub-id-type="pmid">26100751</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0089">
<label>89</label>
<mixed-citation id="mds27484-cit-0089" publication-type="journal">
<string-name>
<surname>Horvath</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Stockler‐Ipsiroglu</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Salvarinova‐Zivkovic</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia: evidence of a phenotypic continuum between dominant and recessive forms</article-title>. <source xml:lang="en"/>Mol Genet Metab
<year>2008</year>;<volume>94</volume>:<fpage>127</fpage>‐<lpage>131</lpage>.<pub-id pub-id-type="pmid">18276179</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0090">
<label>90</label>
<mixed-citation id="mds27484-cit-0090" publication-type="journal">
<string-name>
<surname>Furukawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kish</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Bebin</surname>
<given-names>EM</given-names>
</string-name>, et al. <article-title>Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations</article-title>. <source xml:lang="en"/>Ann Neurol
<year>1998</year>;<volume>44</volume>:<fpage>10</fpage>‐<lpage>16</lpage>.<pub-id pub-id-type="pmid">9667588</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0091">
<label>91</label>
<mixed-citation id="mds27484-cit-0091" publication-type="journal">
<string-name>
<surname>Segawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nomura</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nishiyama</surname>
<given-names>N</given-names>
</string-name>. <article-title>Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease)</article-title>. <source xml:lang="en"/>Ann Neurol
<year>2003</year>;<volume>54</volume>(<issue>Suppl 6</issue>):<fpage>S32</fpage>‐<lpage>S45</lpage>.</mixed-citation>
</ref>
<ref id="mds27484-bib-0092">
<label>92</label>
<mixed-citation id="mds27484-cit-0092" publication-type="journal">
<string-name>
<surname>Wassenberg</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Molero‐Luis</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jeltsch</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Consensus guideline for the diagnosis and treatment of aromatic l‐amino acid decarboxylase (AADC) deficiency</article-title>. <source xml:lang="en"/>Orphanet J Rare Dis
<year>2017</year>;<volume>12</volume>:<fpage>12</fpage>.<pub-id pub-id-type="pmid">28100251</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0093">
<label>93</label>
<mixed-citation id="mds27484-cit-0093" publication-type="journal">
<string-name>
<surname>Al‐Muslamani</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Mahmood</surname>
<given-names>F</given-names>
</string-name>. <article-title>A new tyrosine hydroxylase genotype with orofacial dyskinaesia</article-title>. <source xml:lang="en"/>Sultan Qaboos Univ Med J
<year>2014</year>;<volume>14</volume>:<fpage>397</fpage>‐<lpage>400</lpage>.</mixed-citation>
</ref>
<ref id="mds27484-bib-0094">
<label>94</label>
<mixed-citation id="mds27484-cit-0094" publication-type="book">
<string-name>
<surname>Furukawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kish</surname>
<given-names>S</given-names>
</string-name>. <chapter-title>Tyrosine hydroxylase deficiency</chapter-title> In: <person-group person-group-type="editor"><name><surname>Pagon</surname><given-names>RA</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Adam</surname><given-names>MP</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Ardinger</surname><given-names>HH</given-names></name></person-group>, et al. <source xml:lang="en"/>GeneReviews(R). <publisher-loc>Seattle, WA</publisher-loc>: <publisher-name>University of Washington, Seattle</publisher-name>; <fpage>1993</fpage>‐<lpage>2017</lpage>.</mixed-citation>
</ref>
<ref id="mds27484-bib-0095">
<label>95</label>
<mixed-citation id="mds27484-cit-0095" publication-type="journal">
<string-name>
<surname>Grattan‐Smith</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Wevers</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Steenbergen‐Spanjers</surname>
<given-names>GC</given-names>
</string-name>, <string-name>
<surname>Fung</surname>
<given-names>VS</given-names>
</string-name>, <string-name>
<surname>Earl</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wilcken</surname>
<given-names>B</given-names>
</string-name>. <article-title>Tyrosine hydroxylase deficiency: clinical manifestations of catecholamine insufficiency in infancy</article-title>. <source xml:lang="en"/>Mov Disord
<year>2002</year>;<volume>17</volume>:<fpage>354</fpage>‐<lpage>359</lpage>.<pub-id pub-id-type="pmid">11921123</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0096">
<label>96</label>
<mixed-citation id="mds27484-cit-0096" publication-type="journal">
<string-name>
<surname>Zafeiriou</surname>
<given-names>DI</given-names>
</string-name>, <string-name>
<surname>Ververi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Salomons</surname>
<given-names>GS</given-names>
</string-name>, et al. <article-title>L‐2‐Hydroxyglutaric aciduria presenting with severe autistic features</article-title>. <source xml:lang="en"/>Brain Dev
<year>2008</year>;<volume>30</volume>:<fpage>305</fpage>‐<lpage>307</lpage>.<pub-id pub-id-type="pmid">17981416</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0097">
<label>97</label>
<mixed-citation id="mds27484-cit-0097" publication-type="journal">
<string-name>
<surname>Leuzzi</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Carducci</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Carducci</surname>
<given-names>CL</given-names>
</string-name>, et al. <article-title>Phenotypic variability, neurological outcome and genetics background of 6‐pyruvoyl‐tetrahydropterin synthase deficiency</article-title>. <source xml:lang="en"/>Clin Genet
<year>2010</year>;<volume>77</volume>:<fpage>249</fpage>‐<lpage>257</lpage>.<pub-id pub-id-type="pmid">20059486</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0098">
<label>98</label>
<mixed-citation id="mds27484-cit-0098" publication-type="journal">
<string-name>
<surname>Jäggi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zurflüh</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Schuler</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Outcome and long‐term follow‐up of 36 patients with tetrahydrobiopterin deficiency</article-title>. <source xml:lang="en"/>Mol Genet Metab
<year>2008</year>;<volume>93</volume>:<fpage>295</fpage>‐<lpage>305</lpage>.<pub-id pub-id-type="pmid">18060820</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0099">
<label>99</label>
<mixed-citation id="mds27484-cit-0099" publication-type="journal">
<string-name>
<surname>Kojima</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Anzai</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ohba</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>A female case of aromatic l‐amino acid decarboxylase deficiency responsive to MAO‐B inhibition</article-title>. <source xml:lang="en"/>Brain Dev
<year>2016</year>;<volume>38</volume>:<fpage>959</fpage>‐<lpage>963</lpage>.<pub-id pub-id-type="pmid">27371992</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0100">
<label>100</label>
<mixed-citation id="mds27484-cit-0100" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>WT</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Weng</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>SS</given-names>
</string-name>. <article-title>Microstructural changes of brain in patients with aromatic L‐amino acid decarboxylase deficiency</article-title>. <source xml:lang="en"/>Hum Brain Mapp
<year>2016</year>; <volume>38</volume>:<fpage>1532</fpage>‐<lpage>1540</lpage>.<pub-id pub-id-type="pmid">27859928</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0101">
<label>101</label>
<mixed-citation id="mds27484-cit-0101" publication-type="journal">
<string-name>
<surname>Friedman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Roze</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Abdenur</surname>
<given-names>JE</given-names>
</string-name>, et al. <article-title>Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy</article-title>. <source xml:lang="en"/>Ann Neurol
<year>2012</year>;<volume>71</volume>:<fpage>520</fpage>‐<lpage>530</lpage>.<pub-id pub-id-type="pmid">22522443</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0102">
<label>102</label>
<mixed-citation id="mds27484-cit-0102" publication-type="journal">
<string-name>
<surname>Neville</surname>
<given-names>BG</given-names>
</string-name>, <string-name>
<surname>Parascandalo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Farrugia</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Felice</surname>
<given-names>A</given-names>
</string-name>. <article-title>Sepiapterin reductase deficiency: a congenital dopa‐responsive motor and cognitive disorder</article-title>. <source xml:lang="en"/>Brain
<year>2005</year>;<volume>128</volume>:<fpage>2291</fpage>‐<lpage>2296</lpage>.<pub-id pub-id-type="pmid">16049044</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0103">
<label>103</label>
<mixed-citation id="mds27484-cit-0103" publication-type="journal">
<string-name>
<surname>Koht</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Rengmark</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Opladen</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene</article-title>. <source xml:lang="en"/>Acta Neurol Scand Suppl
<year>2014</year>;(<issue>198</issue>):<fpage>7</fpage>‐<lpage>12</lpage>.<pub-id pub-id-type="pmid">24588500</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0104">
<label>104</label>
<mixed-citation id="mds27484-cit-0104" publication-type="journal">
<string-name>
<surname>Hansen</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Skjørringe</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yasmeen</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Missense dopamine transporter mutations associate with adult parkinsonism and ADHD</article-title>. <source xml:lang="en"/>J Clin Invest
<year>2014</year>;<volume>124</volume>:<fpage>3107</fpage>‐<lpage>3120</lpage>.<pub-id pub-id-type="pmid">24911152</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0105">
<label>105</label>
<mixed-citation id="mds27484-cit-0105" publication-type="journal">
<string-name>
<surname>Rilstone</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Alkhater</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Minassian</surname>
<given-names>BA</given-names>
</string-name>. <article-title>Brain dopamine‐serotonin vesicular transport disease and its treatment</article-title>. <source xml:lang="en"/>N Engl J Med
<year>2013</year>;<volume>368</volume>:<fpage>543</fpage>‐<lpage>550</lpage>.<pub-id pub-id-type="pmid">23363473</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0106">
<label>106</label>
<mixed-citation id="mds27484-cit-0106" publication-type="journal">
<string-name>
<surname>Jacobsen</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Wilson</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cunningham</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Brain dopamine‐serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder</article-title>. <source xml:lang="en"/>J Inherit Metab Dis
<year>2016</year>;<volume>39</volume>:<fpage>305</fpage>‐<lpage>308</lpage>.<pub-id pub-id-type="pmid">26497564</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0107">
<label>107</label>
<mixed-citation id="mds27484-cit-0107" publication-type="journal">
<string-name>
<surname>Ng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Meyer</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood</article-title>. <source xml:lang="en"/>Brain
<year>2014</year>;<volume>137</volume>:<fpage>1107</fpage>‐<lpage>1119</lpage>.<pub-id pub-id-type="pmid">24613933</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0108">
<label>108</label>
<mixed-citation id="mds27484-cit-0108" publication-type="journal">
<string-name>
<surname>DiMauro</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Garone</surname>
<given-names>C</given-names>
</string-name>. <article-title>Metabolic disorders of fetal life: Glycogenoses and mitochondrial defects of the mitochondrial respiratory chain</article-title>. <source xml:lang="en"/>Semin Fetal Neonatal Med
<year>2011</year>;<volume>16</volume>:<fpage>181</fpage>‐<lpage>189</lpage>.<pub-id pub-id-type="pmid">21620786</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0109">
<label>109</label>
<mixed-citation id="mds27484-cit-0109" publication-type="journal">
<string-name>
<surname>McClelland</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Manousakis</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>MS</given-names>
</string-name>. <article-title>Progressive external ophthalmoplegia</article-title>. <source xml:lang="en"/>Curr Neurol Neurosci Rep
<year>2016</year>;<volume>16</volume>:<fpage>53</fpage>.<pub-id pub-id-type="pmid">27072953</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0110">
<label>110</label>
<mixed-citation id="mds27484-cit-0110" publication-type="journal">
<string-name>
<surname>Zhu</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Traboulsi</surname>
<given-names>EI</given-names>
</string-name>, <string-name>
<surname>Parikh</surname>
<given-names>S</given-names>
</string-name>. <article-title>Ophthalmological findings in 74 patients with mitochondrial disease</article-title>. <source xml:lang="en"/>Ophthalmic Genet
<year>2016</year>:<volume>38</volume>:<fpage>67</fpage>‐<lpage>69</lpage>.<pub-id pub-id-type="pmid">27029465</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0111">
<label>111</label>
<mixed-citation id="mds27484-cit-0111" publication-type="journal">
<string-name>
<surname>Vinciguerra</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Federighi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rosini</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Eye movement changes in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)</article-title>. <source xml:lang="en"/>J Neurol Sci
<year>2015</year>;<volume>350</volume>:<fpage>107</fpage>‐<lpage>109</lpage>.<pub-id pub-id-type="pmid">25656101</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0112">
<label>112</label>
<mixed-citation id="mds27484-cit-0112" publication-type="journal">
<string-name>
<surname>Han</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>SH</given-names>
</string-name>. <article-title>Ophthalmological manifestations in patients with Leigh syndrome</article-title>. <source xml:lang="en"/>Br J Ophthalmol
<year>2015</year>;<volume>99</volume>:<fpage>528</fpage>‐<lpage>535</lpage>.<pub-id pub-id-type="pmid">25351680</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0113">
<label>113</label>
<mixed-citation id="mds27484-cit-0113" publication-type="book">
<string-name>
<surname>Cohen</surname>
<given-names>BH</given-names>
</string-name>, <string-name>
<surname>Chinnery</surname>
<given-names>PF</given-names>
</string-name>, <string-name>
<surname>Copeland</surname>
<given-names>WC</given-names>
</string-name>. <chapter-title>POLG‐related disorders</chapter-title> In: <person-group person-group-type="editor"><name><surname>Pagon</surname><given-names>RA</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Adam</surname><given-names>MP</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Ardinger</surname><given-names>HH</given-names></name></person-group>, et al. <source xml:lang="en"/>GeneReviews(®). <publisher-loc>Seattle, WA</publisher-loc>: <publisher-name>University of Washington, Seattle</publisher-name>; <fpage>1993</fpage>‐<lpage>2017</lpage>.</mixed-citation>
</ref>
<ref id="mds27484-bib-0114">
<label>114</label>
<mixed-citation id="mds27484-cit-0114" publication-type="journal">
<string-name>
<surname>Finsterer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zarrouk‐Mahjoub</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Daruich</surname>
<given-names>A</given-names>
</string-name>. <article-title>The eye on mitochondrial disorders</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2016</year>;<volume>31</volume>:<fpage>652</fpage>‐<lpage>662</lpage>.<pub-id pub-id-type="pmid">26275973</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0115">
<label>115</label>
<mixed-citation id="mds27484-cit-0115" publication-type="journal">
<string-name>
<surname>Mellick</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Boyle</surname>
<given-names>R</given-names>
</string-name>. <article-title>Late‐onset presentation of pyruvate dehydrogenase deficiency</article-title>. <source xml:lang="en"/>Mov Disord
<year>2004</year>;<volume>19</volume>:<fpage>727</fpage>‐<lpage>729</lpage>.<pub-id pub-id-type="pmid">15197721</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0116">
<label>116</label>
<mixed-citation id="mds27484-cit-0116" publication-type="journal">
<string-name>
<surname>Head</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Zolkipli</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Shahdadpuri</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>King</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Clayton</surname>
<given-names>PT</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>GK</given-names>
</string-name>. <article-title>Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency</article-title>. <source xml:lang="en"/>Ann Neurol
<year>2005</year>;<volume>58</volume>:<fpage>234</fpage>‐<lpage>241</lpage>.<pub-id pub-id-type="pmid">16049940</pub-id></mixed-citation>
</ref>
<ref id="mds27484-bib-0117">
<label>117</label>
<mixed-citation id="mds27484-cit-0117" publication-type="journal">
<string-name>
<surname>Sofou</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Dahlin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hallböök</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lindefeldt</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Viggedal</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Darin</surname>
<given-names>N</given-names>
</string-name>. <article-title>Ketogenic diet in pyruvate dehydrogenase complex deficiency: short‐ and long‐term outcomes</article-title>. <source xml:lang="en"/>J Inherit Metab Dis
<year>2017</year>;<volume>40</volume>:<fpage>237</fpage>‐<lpage>245</lpage>.<pub-id pub-id-type="pmid">28101805</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>